Studies on the hyaluronidase enzyme purified from the venom of Chinese red scorpion Buthus martensi Karsch by FENG LUO
 
 
STUDIES ON THE HYALURONIDASE ENZYME PURIFIED 































NATIONAL UNIVERSITY OF SINGAPORE 
2010 
 
STUDIES ON THE HYALURONIDASE ENZYME PURIFIED 












for the degree of  
DOCTOR OF PHILOSOPHY  
in the 














Department of Anatomy 
Yong Loo Lin School of Medicine 





I would like to take this opportunity to express my sincere appreciation to my supervisor 
Prof. P. Gopalakrishnakone, Department of Anatomy, National University of 
Singapore. During my study in Anatomy, I owed much to his great patience, academic 
guidance and endlessly encouragement. It is my luck to study under his supervision. 
 
I’d also like to thank Prof. Bay Boon Huat, the head of Department of Anatomy, 
National University of Singapore, for his management to make the whole department as a 
big family and hence I could enjoy the stay in the department.  
 
I will not forget the great support from Dr. Gao Rong. I have learned much from him, 
from the understanding of the science to the techniques of the experiments. I felt so 
happy to meet such a big brother in the lab.  
 
I would also thank Dr. M.M.Thwin, the senior member of Venom and Toxin Research 
Programme, who helped me in writing the manuscript, patiently listened to my queries 
and unselfishly shared his experience. He was always available when I needed the help.  
 
I highly appreciate the kindly help of Mr. Meng Jun, Dr. R. Saminathan, Ms. Hema 
D/O Jethanand for my research activities and thank as well to Dr. P. Saravanan, Dr. A. 
Pachiappan, Dr. Perumal Samy, and all other Venom and Toxin Research Programme 
members, for maintaining a favorable working environment. 
 I
 I would like to thank Ms Yong Eng Siang, Ms Ng Geok Lan, for their efficient 
organization to keep the lab clean and safe, Ms Violet Teo, Ms Carolyne Ang and Ms 
Diljit Kour d/o Bachan Singh, for their secretarial assistance. I also wish to thank all the 
Department staffs and students; I will never forget the life in the Department. 
 
I would also like to show the gratitude to my family. My parents’ support and tolerance is 
always the drive for me to step forward.  
 
Last but not least, I would acknowledge the National University of Singapore, for 














TABLE OF CONTENTS 
Acknowledgements                                                                                                             I 
Table of Contents                                                                                                            III 
Summary                                                                                                                       VIII 
Publications                                                                                                                       X 
Abbreviations                                                                                                                 XII 
 
CHAPTER 1: INTRODUCTION  
1.1 Venomous animals and their venoms                                                                             
1.2 Scorpion biology                                                                                                             
1.3 Scorpion venom                                                                                                              
        1.3.1 Sodium channel toxins                                                                                         
        1.3.2 Potassium channel toxins                                                                                     
        1.3.3 Calcium channel toxins                                                                                        
        1.3.4 Chloride channel toxins                                                                                       
        1.3.5 Peptides not targeting on ion channels                                                              
1.4 Low molecular weight toxins from the venom of BmK scorpion                                 
1.5 High molecular weight proteins from animal venoms                                                  
1.6 Hyaluronidase and its substrate hyaluronan (formerly hyaluronic acid)                      
1.7 Venom hyaluronidases                                                                                                  
1.8 Structures of hyaluronidases                                                                                         
1.9 The biological and medical applications of hyaluronidases                                         

















 CHAPTER 2: MATERIALS AND METHODS 
2.1 The venom                                                                                                                    
2.2. Gel filtration of BmK crude venom and molecular weight distribution of fractions   
2.3 The screening of the biological activities of BmK crude venom and its gel filtration    
33 
33 
      fractions                                                                                                                         
2.4 The purification of BmHYA1                                                                                       
34 
38
    2.4.1 Gel filtration                                                                                                           
    2.4.2 Anion exchange chromatography                                                                          
    2.4.3 Cation exchange chromatography                                                                          
    2.4.4 Reversed-phase high-performance liquid chromatography                                   
2.5 Characterization of BmHYA1                                                                                     
    2.5.1 SDS-PAGE                                                                                                            
    2.5.2 Mass spectrometry                                                                                                 
    2.5.3 N-terminal sequencing                                                                                           
    2.5.4 Optimal pH and temperature                                                                                  
    2.5.5 Thermostability                                                                                                      
    2.5.6 Km and Vmax determination                                                                                    
    2.5.7 Deglycosylation of BmHYA1                                                                                
    2.5.8 Effect of inhibitors on hyaluronidase activity                                                        
    2.5.9 Thin-layer chromatography for determination of the final degradation  
             product                                                                                                                   


















    2.6.1 Total RNA extraction                                                                                            44 
    2.6.2 First strand cDNA synthesis from Total RNA                                                      47 
    2.6.3 3’ rapid amplification of cDNA ends                                                                    48 
        2.6.3.1 Design of degenerate GSP                                                                             48 
        2.6.3.2 Amplification of 3’ end cDNA of BmHYA1 with PCR                                49 
        2.6.3.3 Agarose gel electrophoresis                                                                           51 
        2.6.3.4 Isolation of DNA from agarose gel                                                                52 
    2.6.4 Enzymatic manipulation of DNA                                                                         53 
        2.6.4.1 DNA ligation                                                                                                  53 
        2.6.4.2 DNA digestion                                                                                               53 
        2.6.4.3 Heat shock transformation and white/blue screening                                    54 
        2.6.4.4 Isolation of plasmids from the bacteria                                                          55 
        2.6.4.5 Verification of the insert fragment                                                                 56 
        2.6.4.6 DNA sequencing                                                                                            57 
    2.6.5 Protein sequence analyzing                                                                                   57 
    2.6.6 Expression of BmHYA1                                                                                       59 
2.7. Biological activity test                                                                                                60 
    2.7.1 Cell culture                                                                                                            60 
    2.7.2 Immunohistochemical staining for hyaluronan                                                    61 
    2.7.3 Western blot analysis for investigating the effect of the enzyme on the  
             expression of cancer-related biological molecule                                                 61 
2.8 Statistical analysis                                                                                                        62 
 
 V
CHAPTER 3: RESULTS AND OBSERVATIONS 
3.1 The crude venom                                                                                                         
3.2 Preliminary separation of BmK crude venom and biological activity screening        
    3.2.1 Preliminary separation of BmK crude venom                                                      
    3.2.2 L-amino acid oxidase activity                                                                               
    3.2.3 Fibrinogenolytic activity                                                                                      
    3.2.4 Hemolytic activity                                                                                                
    3.2.5 Antibacterial activity                                                                                            
    3.2.6 Amidolytic activity                                                                                             
    3.2.7 Phospholipase A2 activity                                                                                   
    3.2.8 Hyaluronidase activity                                                                                        
3.3. Purification of BmK venom hyaluronidase BmHYA1                                             
    3.3.1 Gel filtration chromatography                                                                              
    3.3.2 Anion exchange chromatography                                                                       
    3.3.3 Cation exchange chromatography                                                                        
    3.3.4 Reversed-phase high-performance liquid chromatography                                 
3.4. Homogeneity and molecular weight of BmHYA1                                                   
3.5 N-terminal sequence of BmHYA1                                                                              
3.6 Optimal pH profile                                                                                                      
3.7 Optimal temperature profile                                                                                        
3.8 Thermostability                                                                                                           
3.9 Km and Vmax determination                                                                                          


















  78 
  78 
  78 
  84 
  84
  84 
  84
  84





























3.11 Deglycosylation assays                                                                                           
3.12 End products of hydrolysis of hyaluronan by BmHYA1                                       
3.13 The molecular biological study                                                                               
    3.13.1 RNA isolation and integrity test                                                                      
    3.13.2 RT-PCR and 3’ rapid amplification of cDNA ends                                         
    3.13.3 TA cloning of the 1.3 kb fragment                                                                   
    3.13.4 3’ end cDNA nucleotide and full length protein sequences of BmHYA1       
    3.13.5 Expression of BmHYA1 in E.coli system                                                       
      3.13.5.1 Cloning of BmHYA1 cDNA in pET41a(+) vector                                     
      3.13.5.2 Expression of recombinant BmHYA1                                                        
3.14 The biological activity investigation of BmHAY1                                                 
    3.14.1 Direct effect of BmHYA1 on cultured cancer cells                                         
    3.14.2 BmHYA1 and the expression of CD44 isoforms                                             
 
CHAPTER 4: DISCUSSIONS 
4.1 The protein content of the animal crude scorpion venom                                         
4.2 The biological activities of BmK crude venom                                                         
4.3 The purification and characterization of BmHYA1                                                  
4.4 The N-terminal amino acids sequence of BmHYA1                                                
4.5 The cloning and expression of BmHYA1                                                                 
4.6 Biological activities of BmHYA1                                                                             












REFERENCES                                                                                                              
    96 












































      The present work includes 1) screening of the biological activities in scorpion Buthus 
martensi Karsch (BmK) crude venom; 2) the purification and characterization of the 
hyaluronidase enzyme (BmHYA1) from the venom of BmK; 3) the cDNA cloning and 
expression of BmHYA1 and 4) the preliminary pharmacological study of BmHYA1.  
 
      Scorpion venom is a rich source for short neurotoxic peptides but this study indicates 
it also contains various high molecular weight (M.W.) proteins. A number of enzymatic 
activities have been detected in the present work including L-amino acid oxidase (LAAO), 
serine protease, and hyaluronidase. It is also possible to contain Phospholipase A2 (PLA2) 
and metalloproteinase. This work should be the pioneer in comprehensive investigation of 
the enzymatic proteins in scorpion BmK venom. 
 
      The hyaluoridase from the crude venom of BmK, later named as BmHAY1, was 
studied in detail. The enzyme was purified from the crude venom by a successive 
chromatography of gel filtration, ion-exchange and reversed-phase high-performance 
liquid chromatography (RP-HPLC). The homogeneity was manifested by dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), matrix assisted laser desorption 
ionisation time-of-flight mass spectrometry (MALDI-TOF MS) and Edman degradation. 
MALDI-TOF result also showed its molecular weight of 48,696 Da. Its N-terminal amino 
acids were determined by Edman degradation and showed homologies to other venom 
hyaluronidases to some degree. BmHYA1 has an optimal temperature of 50 oC and 
 VIII
optimal pH of 4.5.  Its Km and Vmax are determined to be 95.3 µg/mL and 3.9 µg/min, 
respectively. Additionally, the enzyme can hydrolyze the substrate hyaluronan into 
tetrasacchrides.  
 
      Rapid amplification of cDNA ends- polymerase chain reaction (RACE PCR) 
technique was used to clone the 3’ end BmHYA1 cDNA sequence. The 5’ degenerate 
primer was designed based on known N-terminal sequence hence the whole mature 
BmHYA1 sequence was deduced.  This is also the first hyaluronidase full protein 
sequence from the scorpion species. The alignment shows it has some homologies (up to 
34%) to other Glycol-Hydro-56 family members. The phylogenetic analysis indicates 
early divergence and independent evolution of BmHYA1 from other hyaluronidase 
family members. The recombinant BmHYA1 was expressed in E.coli but did not show 
the activity. 
 
      The treatment with BmHYA1 to MDA-MB-231 breast cancer cells gave rise to the 
removal of hyaluronan from the cell surfaces. The further study about its effect on CD44 
molecules showed that the environmental hyaluronidase (BmHYA1) can modulate the 
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Chapter 1: Introduction 
1.1 Venomous animals and their venoms 
Venomous animals produce lethal secretion known as venom from specialized 
venom glands. In animal kingdom, there are many creatures, e.g., snakes, scorpions, 
spiders and bees, etc., which may be different in morphology, habit, species and size, 
but they all share one remarkable specialty of producing the venoms.  
 
Venomous animals employ venoms for defensive or offensive purpose. The 
venom can paralyze or even kill the victim in a very short time. The components in 
animal venoms accounting for these biological effects are mainly proteins or peptides. 
According to their molecular sizes, the venom proteins can be roughly classified into 
two groups: high M.W. enzymes, which are involved in various biochemical 
processes, and low M.W. peptides, which act mainly on numerous ion 
channels/receptors.  
 
These properties make animal venoms a rich source for biomedical scientists in 
search of novel molecules to study biological phenomena or treat human disorders.  
 
1.2 Scorpion biology 
The scorpion is one of the most important sources of venom which has been 
widely studied. They are one of the oldest creatures which have been in existence on 
earth for millions of years since the middle Silurian (about 425~450 million years ago) 
period. Scorpions are widely distributed, with over 1,500 species reported so far 
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(Polis, 1990), and can be found in all the continents except Antarctica (Fig. 1.1). 
Scorpions belong to arthropods and have a large family. Under the class Arachnida, 
there are nine families: Bothriuridae, Buthidae, Chactidae, Chaerilidae, 
Diplocentridae, Ischnuridae, Iuridae, Scorpionidae and Vaejovidae (Sissom, 1990). 
The family Buthidae, containing 48 genera and more than 500 species, is supposed to 
be the largest and most widespread species among these families (Sissom, 1990). 
Buthidae is also considered as the medically important scorpion family (Fet and Lowe, 
2000; Simard and Watt, 1990). Scorpion Buthus martensi Karsch (BmK), the Chinese 
red scorpion (also called East Asian scorpion, note: scorpion Mesobuthus tamales is 
usually called Indian red scorpion), which belongs to Buthidae family, is the most 
commonly found scorpion in mainland China.  
 
    The BmK Scorpion is yellowish to brown in color, and with the length (including 
the tail) of up to 6 cm, it is generally small in size as compared to other scorpion 
species (Fig. 1.2). It is not aggressive, and its venom toxicity is considered to be 
moderate and non-lethal to human (Goudet et al., 2002). The venom is produced and 
secreted from the venom gland which is located in the telson (the last segment of the 
metasoma. Fig. 1.2). In telson, there is a pair of venom glands each on either side of 


















Fig. 1.1. Geographic distribution of scorpions whose venoms have been mostly 
studied. Aah, Androctonus australis hector; Amm, Androctonus mauretanicus 
mauretanicus; Be, Buthus epeus; Bom, Buthus occitanus mardochei; Bot, Buthus 
occitanus tunetanus; Ce, Centruroides sculpturatus; Clt, Centruroides limpidus; Css, 
Centruroides suffuses suffuses; Cn, Centruroides noxius; Lqq, Leirus quinquestriatus 
quinquestriatus; Lqh, Leiurus quinquestriatus hebraeus; BmK, Buthus martensi 























Fig. 1.2. Buthus martensi Karsch (Chinese red scorpion). Wild-specimen from 
Xuzhou, Jiangsu Province, PR China. Inset: Segments of metasoma and telson 











Chapter 1: Introduction 
The medical significance of BmK scorpion itself has been recorded for more than 
a thousand years. In China, during the Song Dynasty (A.D. 960-1279), the medical 
use of the BmK scorpion body was recorded in the official pharmaceutical book Kai 
Bao Ben Cao (Kai Bao, referring to a time period from 968-975; Ben Cao means 
“herbs”). In another pharmacopoeia, Ben Cao Gang Mu (Compendium of Materia 
Medica, A.D.1578), which is probably the most famous Chinese pharmacopoeia book, 
the medicinal use of scorpions was described in detail as anti-epilepsy, analgesic, 
anticoagulant and anti-rheumatism agents.  
 
1.3 Scorpion venom 
        Scorpion venom is produced and secreted by the venom glands. When needed, 
the scorpion erects the tail and stings the victim with its telson to inject the venom 
into the victim’s body. The venom can also be milked by electrical stimulation. 
Generally, 1 gram of dry crude venom could be collected from 3000 scorpions 
(information from the venom supplier). The first drop of the venom (called pre-venom) 
is transparent and clear, but becomes milk-white and mucous later on. The 






















Fig. 1.3. Representative diagram of scorpion venom glands. ① cuticle ② skeletal 










Chapter 1: Introduction 
        The venom of scorpion is a very complex mixture, which is composed of mucus, 
salts, various small neurotransmitters (e.g., serotonin, histamine, acetylcholine and 
norepinephrine), low M.W. peptides (mainly 3~8 kDa neurotoxins) and high M.W. 
enzymes (Polis, 1990; Martin-Eauclaire and Couraud, 1995; Nirthanan et al., 2002). 
The proteins in the venoms attract the most attention due to their significant 
medical/scientific applications. 
 
        Small peptides in scorpion venoms are mainly neurotoxins which may modulate 
various ion channels on excitable cells. Possessing a broad spectrum of specificity for 
ion channels, they are also valuable tools as molecular probes for the basic 
neuroscience research. Scorpion neurotoxins can be classified according to the 
different ion channels they target, though there are several other species of peptides 
that do not target ion channels. 
 
        1.3.1 Sodium channel toxins 
        The sodium channel toxin was the first neurotoxin purified from the scorpion 
venom (Rochat et al., 1967). They are usually long chain peptides (60~70 amino acids) 
with four disulfide bonds (Possani et al., 1999). On the basis of different targeted sites 
on sodium channel, they are further divided into α- and β-toxins (Couraud et al., 
1982). Voltage-gated sodium channels (VGSCs) consist of an α subunit and two β 
subunits (β1 and β2). Scorpion α-toxins interact with the domain in α subunit 
(neurotoxin receptor site 3 of VGSCs), while β-toxins bind to the domain located in 
 7
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β1 subunit (neurotoxin receptor site 4 of VGSCs) (Jover et al., 1988; Martin-Eauclaire 
et al., 1995). Hence, there is no competitive relationship between these two groups. 
The α-toxins can prolong the action potential, and therefore inhibit or slow down the 
inactive process of sodium channel. The β-toxins may increase sodium current by 
shifting the threshold of activation to hyperpolarized potentials (Couraud et al., 1982; 
Marcotte et al., 1997). The sodium channel scorpion toxins that specifically act on 
mammals and insects are classified into vertebrate sodium channel toxins and insect 
sodium channel toxins, respectively. The latter can be further divided into two groups: 
the excitatory and the depressant insect toxins. (Goudet et al., 2002; Martin-Eauclaire 
et al.,1995).  
 
        1.3.2 Potassium channel toxins 
        Potassium channels have a large family. Voltage-gated potassium channel 
blockers may inhibit cellular proliferation and suppress cellular activation, through 
the modulation of calcium influx (Wulff et al., 2009). Scorpion toxins can specifically 
target at three potassium channel types: the delayed rectifier potassium channels, the 
transient (or A-type) potassium channels and the calcium-dependent potassium 
channels (Hille, 1991). Based on structural homology, they fall into 17 sub-families, 
termed α-KTx1-17 (Tytgat et al., 1999; Zhang et al., 2004a; Wang et al., 2005). Most 
scorpion potassium channel blockers are relatively short peptides (30-40 amino acids) 
with three or four disulfide bridges (Garcia et al., 2001). On the other hand, some long 
chain potassium toxins have been purified or cloned from scorpion venoms and may 
 8
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therefore form new classes (Yao et al., 2005; Legros et al., 1998). The scorpion 
potassium toxins have played a crucial role in elucidating the structure of KcsA 
channel, a potassium selective channel from Streptomyces lividans (Lu and 
MacKinnon, 1997; Garcia et al., 2001).  
 
        1.3.3 Calcium channel toxins 
        Voltage-gated calcium channels are involved in several physiological or 
pathological progresses, e.g., in pain pathways (Zamponi et al., 2009). Calcium 
channel toxins are able to exert pharmacological effect on these progresses and are 
considered to be the potential treatment of chronic pain (Norton and McDonough, 
2008). Several calcium channel-related toxins were purified or cloned from scorpion 
venoms. Toxin II.6 from the venom of scorpion Centruroides limpidus showed 
inhibitory effect on the classical Ca2+ current activated at high membrane potentials. It 
was also reported to have a modulatory effect on sodium channel activities. (Alagón 
et al., 1988). A β scorpion toxin Tityus gamma, from the venom of scorpion Tityus 
serrulatus, was able to release calcium from the intracellular IP3-sensitive calcium 
stores. (Fernandes et al., 2004). From the venom of scorpion Pandinus imperator, 
toxins called Tetrapandins were found to specifically inhibit the store-operated 
calcium entry in human embryonic kidney-293 cells, and were thought to be a new 
toxin class (Shalabi et al., 2004). 
 
        1.3.4 Chloride channel toxins  
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        So far only two chloride channel toxins have been identified: one is chlorotoxin, 
with a short peptide chain (36 residues) from the venom of scorpion Leiurus 
quinquestriatus (DeBin et al., 1993), and the other one is from the BmK venom (to be 
addressed later). Chlorotoxin was considered to specifically target on chloride 
channels and was found to have specifically inhibitory effect on glioma (DeBin et al., 
1993; Dalton et al., 2003). But it was found later that its inhibitory effect on glioma 
was by inhibiting matrix metalloproteinase 2, which was also up-regulated in glioma 
(Deshane et al., 2003). Because of the specific effect seen on glioma, chlorotoxin has 
been extensively studied for its potential therapeutic use (Lyons et al., 2002; Deshane 
et al., 2003).  
  
        1.3.5 Peptides not targeting on ion channels 
        The classes of scorpion toxins that do not target on ion channels include: (1) 
antimicrobial toxins; (2) bradykinin-potentiating peptides and (3) serine protease 
inhibitors. Antimicrobial toxins have no disulfide bridge. They are usually cationic or 
amphipathic small (2~5 kDa) peptides essentially having an alpha helical structure 
(Hwang and Vogel, 1998). A number of such peptides have been purified and 
characterized from scorpion venoms (Conde et al., 2000; Corzo et al., 2001; Moerman 
et al., 2002; Lee et al., 2004), and they can be provisionally classified into 6 
subfamilies (Zeng et al., 2005). Probably due to their pore-forming ability, they have 
an immense potential in antimicrobial applications (Nomura et al., 2004; Nomura et 
al., 2005). Bradykinin-potentiating peptides also have no disulfide bridges. It was first 
 10
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purified from the venom of T. serrulatus (Ferreira and Henrigques, 1992), and later 
identified in Buthus occitanus and Buthus martentsi scorpion venoms as well (Meki et 
al., 1995; Zeng et al., 2000). From the venom of scorpion Tityus serrulatu, a serine 
protease inhibitor, with the M.W. of 4,489 Da, was purified. It showed inhibitory 
activity against the rat plasma and urine kallikrein, and porcine pancreatic kallikrein 
(Ferreira et al., 1998). 
 
1.4 Low M.W. toxins from the venom of BmK scorpion 
        More than 70 peptides with various activities have already been discovered from 
the BmK scorpion venom (Goudet at al., 2002). This venom contains all the ion 
channel toxins including sodium channel toxins, potassium channel toxins, chloride 
channel toxins and calcium channel toxin (Goudet et al., 2002; Cao et al., 2006). 
Additionally, it also has toxins without disulfide bond (Zeng et al., 2005).  
 
        BmK toxins targeting sodium channels have been extensively studied. They are a 
group of toxins with relatively long peptide chains, consisting normally of 60~70 
amino acids with 4 disulfide bridges. Thus far, more than 50 sodium channel peptides 
have been identified in BmK venom (Goudet et al., 2002). Several sodium BmK 
toxins were previously purified and characterized in our laboratory. Gong et al. (1997) 
isolated an α-neurotoxin named Makatoxin I from the venom of BmK, and revealed 
that it had nitrergic activity, which would lead to a relaxant responses by the release of 
inhibitory neurotransmitter nitric oxide. Another toxin termed Chibutoxin, which was 
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subsequently isolated by our group (Gong et al., 1998), manifested adrenergic 
transmission inhibitory activity. Bukatoxin, an α-toxin purified from the venom of 
BmK (Srinivasan et al., 2001) caused significant relaxant responses in the carbachol-
precontracted rat anococcygeus muscle. A synthetic peptide (Buka11) representing the 
core potential activity domain of BmK was examined, and found to be responsible for 
this relaxant activity. 
 
The toxins targeting the potassium channels from BmK venom have relatively 
shorter peptide chains consisting usually of 30~40 amino acids that are commonly 
stabilized by 3 disulfide bridges. Long chain potassium channel peptides containing 
more than 60 amino acids have also been found in the BmK venom. A long chain 
potassium toxin BmP09 have been characterized (Yao et al., 2005) and two 
homologues have been cloned (Zhu et al., 1999). In total, more than 20 BmK 
potassium toxins have been discovered so far (Goudet et al., 2002; Sheng et al., 2004; 
Xu et al., 2004a; Xu et al., 2004b; Yin et al., 2008). 
 
Besides, chloride channel toxin or chlorotoxin homologues, calcium toxin, and 
toxins without disulfide bridge have also been found in the BmK venom. Chlorotoxin 
homologues in BmK venom have been reported years before but no function was 
described (Wu et al., 2000; Zeng et al., 2000; GenBank accession No.: AAK16444.1). 
Recently, a chlorotoxin-like neurotoxin has been successfully expressed and verified 
to have similar function as chlorotoxin (Fu et al., 2007). In 2006, the first calcium 
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toxin from BmK venom, termed BmCa1, has been cloned and characterized. The 
precursor has 64 residues, and the mature peptide contains 37 amino acids (Cao et al., 
2006). So far, four disulfide-bond-free toxins have been cloned from BmK venom, 
with some tested to have antibiotic activities. (Zeng et al., 2004). 
 
In sum, BmK low M.W. toxins have been extensively studied resulting in a 
deeper understanding of structure-function relationship of ion channels, and a wider 
scope for the therapeutic potential. In fact, the toxins of BmK venom are considered 
the most studied scorpion toxins in the world (Goudet et al., 2002). Their abundant 
source and marked significance attracted the researchers to focus on them and make 
an enormous contribution to related research fields. However, the emphasis on the 
small peptides probably attribute to the overlooking of large proteins from the same 
source. Prior to this work, no attempt has been made to address the issues of high 
M.W. proteins from the venom of BmK. 
 
1.5 High M.W. proteins from animal venoms 
        High M.W. proteins in the venom are mainly the water-soluble enzymes. The 
enzymes commonly found in venoms are hydrolases including proteinases, 
phosphodiesterases, exo-/endo-peptidases and phospholipases (Hider et al., 1991). 
Snake venoms are an important source for the venom enzymes and have been 
intensively studied. Enzymes have also been identified in other venomous sources like 
bees, scorpions, spiders and fishes. These enzymes include L-amino acid oxidase, 
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phospholipases A2, serine protease, metalloproteinases, hyaluronidases, etc.. Other 
than these enzymes, some significant high M.W. non-enzymatic proteins also exist in 
animal venoms. 
 
    L-amino acid oxidase (LAAO): 
    LAAO is a flavoenzyme widely distributed in various organisms including animal 
venoms. In the presence of water and oxygen, it can catalyze stereospecific oxidative 
deamination of an L-amino acid substrate to ammonia, corresponding α-keto acid and 
hydrogen peroxide. LAAOs are the major components in many snake venoms and 
have been intensively studied. Most of the identified LAAOs have been 
enzymologically characterized (Du and Clemetson, 2002; Zhang and Wu, 2008), and 
some LAAOs, like the ones from the venoms of Trimeresurus flavoviridis, 
Eristocophis macmahoni, Agkistrodon halys blomhoffii and Ophiophagus hannah 
(Abe et al., 1998; Ali et al., 2000; Takatsuka, 2001; Jin et al., 2007) have been 
elucidated structurally. With the aid of X-ray crystallography, Pawelek et al. (2000) 
have revealed that LAAO from the venom of C.rhodostoma is functionally a dimer. 
Crystal structures of venom LAAOs from and Agkistrodon halys pallas, Calloselasma 
rhodostoma and Vipera ammodytes ammodytes (Zhang et al., 2004b; Moustafa et al., 
2006; Georgieva et al., 2008) have also been established. LAAOs have various 
biological activities, including their marked inhibitory and activating effects on 
platelet function, induction of apoptosis, etc. (Du and Clemetson, 2002).  
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    Phospholipase A2(PLA2) 
    PLA2 is a common enzyme found in mammalian tissues as well as in animal 
venoms. Generally, PLA2 specifically attacks sn-2 ester bond of phospholipids, and 
hydrolyzes it into arachidonic acid and lysophospholipid, which ultimately lead to 
many inflammatory processes. Hence, PLA2 can be considered as inflammation 
upstream modulator (Dennis, 1994). However, it has rather broad biological activities; 
it can induce nerve growth, and has antibacterial activity, cytotoxicity and 
anticoagulation effect (Nevalainen et al., 2008; Makarova et al., 2007; Bonfim et al., 
2006; Mounier et al., 2001). PLA2 may fall into 3 subfamilies: secretory 
phospholipases A2 (sPLA2), cytosolic phospholipases A2 (cPLA2) and lipoprotein-
associated PLA2s (lp-PLA2). All the venom PLA2s are sPLA2s, and their 
enzymological, pharmacological and even structural properties have been well 
characterized (Teixeira et al., 2003; Kini, 2003; Arni and Ward, 1996).  
 
    Serine protease  
    Serine proteases have a serine residue in the active sites of their molecules. Serine 
proteases have a variety of activities, and have been isolated and characterized from 
many animal venoms. Snake venom serine proteases have been found to possess both 
procoagulant and anticoagulant activities. Procoagulatant serine proteases, like the 
activators of factor V (Tokunaga et al., 1988), factor VII (Nakagaki et al., 1992), 
factor Χ (Tans and Rosing, 2001), prothrombin activators (Kini, 2005) and thrombin-
like enzymes (Pirkle, 1998), as well as some anticoagulant proteases, like protein C 
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activators (Kisiel et al., 1987; Bakker et al., 1993) have been isolated from various 
snake venoms. Some of the snake venom fibrinolytic proteases (Zhang et al., 1995; 
Wisner et al., 2001) and kininogenase (kallikrein-like) proteins (Matsui et al., 1998) 
are also serine proteases. Besides their presence in snake venoms, serine proteases 
have also been found in the venoms of scorpions (Almeida et al., 2002) and spiders 
(Devaraja et al., 2008; Veiga et al., 2000), but the available data are rather limited as 
compared to the accumulated data available for snake venom proteases. Amidolytic 
activity test is a common assay to identify the serine protease from the venoms 
(Zhang et al., 1998a). 
 
     Metalloproteinases 
    Metalloproteinases, another member of the protease family, are commonly found in 
the spaces between cells, and hence are known as extracellular matrix 
metalloproteinase proteins (MMPs). As indicated by the name, a metal is needed for 
their activity. Most of them are zinc-dependent, and their activity can therefore be 
significantly inhibited by EDTA. Metalloproteinases are commonly found in animal 
venoms, and they exert various activities, amongst which the effect on the hemostatic 
system is the most significant. They fall into two classes: hemorrhagic and non-
hemorrhagic. Both of them are fibrin(ogen)olytic enzymes, cleaving the Aα-chain in 
preference to the Bβ-chain (Markland, 1998). Snake venom metalloproteinases 
(SVMPs) also have the biological activities related to apoptosis (Wu et al., 2001; 
Masuda et al. 2001), proteolysis (Jeon and Kim, 1999), inflammation (Teixeira et al., 
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2005) and inhibition of L-type Ca2+ channels (Zhang et al., 2009). All venom 
metalloproteinases that have been found so far are zinc-dependent enzymes with a 
Zn2+-binding motif of HEXXHXXGXXH (Matsui et al., 2000). Many of them possess 
disintegrin domains as well (Ramos and Selistre-de-Araujo, 2006). Metalloproteinases 
have also been isolated and characterized in animal venoms other than those of snakes 
(e.g., in spider venom, Nagaraju et al., 2007), but the data are rather limited.  
 
    C-type lectin-like protein and Nerve growth factor 
    C-type lectin-like proteins are commonly found in snake venoms. They have the 
disulfide-bonding pattern similar to C-type lectins, but usually lack the calcium-
dependent and sugar-binding properties of classical C-type lectins (Atoda et Morita, 
1993). C-type lectin-like proteins mainly have the effect on platelet functions and 
hemostasis (Clemetson et al., 2005). It has also been isolated from the scorpion 
venom (Khoang et al., 2001).  
    Snake venom is one of the first sources available for isolation of NGFs, which are 
responsible for maintaining neurons and supporting their survival. Snake venom 
NGFs contain two identical or very similar subunits, and usually have the M.W. of 
more than 25,000 Da. As revealed by structural analysis, snake venom NGFs have 
amino acid sequences similar to those of the mammalian NGFs, (Kostiza and Meier, 
1996). A recent study indicates that NGFs may facilitate the prey activity of 
venomous animals (Gennaro et al., 2007). NGFs are initially thought to be absent in 
the venoms of bees, scorpions, toads and spiders (Pearce, 1973) until Lipps (2000) has 
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successfully purified NGF from the honeybee venom. They are also known to be 
present in scorpion venoms (Lipps, 2000). 
 
1.6 Hyaluronidase and its substrate hyaluronan (formerly hyaluronic acid) 
        Hyaluronidases are a group of neutral- and acid-active enzymes found 
throughout the animal kingdom in organisms as diverse as microbes, bees, wasps, 
hornet, spiders, scorpions, fish, snakes, lizards, and mammals (Kemparaju and Girish, 
2006; Stern and Jedrzejas, 2006). They can hydrolyze the substrate hyaluronan, which 
is found predominantly in connective tissues, skin, cartilage, and in synovial fluid of 
mammals (Delpech, 1997). Hyaluronidases could be divided into three groups 
according to their action mechanisms: 1) endo-β-N-acetyl-hexosaminidases group 1, 
EC 3.2.1.35 (mainly found in vertebrates); 2) endo-β-N-acetyl-hexosaminidases group 
2 EC 4.2.99.1 (mainly found in bacteria); and 3) endo-β-glucuronidases EC 3.2.1.36 
(hyaluronidases from leech and crustaceans). The first two classes are well studied, 
but the third class remains little known. In human proteomics, there are 5 
hyaluronidases expressed: Hyaluronidase-1 to -4 and PH-20. Except for PH-20, which 
mainly associates with the testes, the first 4 homologues distribute widely in the body. 
The other important source of hyaluronidases is animal venoms. Hyaluronidases act 
as a “spreading factor” in animal venoms to facilitate the penetration of other toxins 
during the envenomation (Duran-Reynals, 1933). 
     
        In bacteria, all the bacterial hyaluronidases are lyases. Beacteria employ their 
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hyaluronidases for two purposes: 1) to overcome the defense system of the host by 
degrading hyaluronan, one of the major components of the tissue extracellular matrix 
(ECM); 2) to make use of disaccharide, the degradation product that can provide the 
bacteria with the carbon and energy (Stern and Jedrzejas, 2005). 
 
        As the substrate of hyaluronidases, hyaluronan is a linear polysaccharide linked 
by as many as 25,000 repeating units of disaccharides (D-glucuronic acid and D-N-
acetylglucosamine) (Fig. 1.4). It is the primary composition of ECM, and its 
degradation and synthesis are in dynamic equilibrium at any moment. Degradation of 
hyaluronan by hyaluronidase is accomplished by cleavage at either β1,3 glycosidic 
bond or β1,4 glycosidic bond, but the cleavages at β 1,4 glycosidic bond are much 
more common (Stern and Jedrzejas, 2006). Different hyaluronidases may produce the 
digestion product in different sizes. The resulting fragments interact with different 
receptors of the cell membrane and induce correspondingly downstream 
physiological/pathological events, such as anti-angiogenesis, cell invasion/motility 

















Fig. 1.4. Chemical structure of hyaluronan. Hyaluronan polymer is composed of the 
repeating units of glucuronic acid and N-acetylglucosamine. n: 20~25,000. Freely 
licensed image from Wikipedia. 
 
 
1.7 Venom hyaluronidases 
        So far, a number of hyaluronidases have been isolated from the venoms of bees, 
snakes, wasps, hornets, spiders and fish (Gmachl and Kreil, 1993; Xu et al., 1982; 
Kudo and Tu, 2001; Girish et al., 2004; King et al., 1996; Lu et al., 1995; Wright et al., 
1973; Poh et al., 1992).  Hyaluronidase activity has been identified in the brown 
recluse spider venom by Wright et al. (1973), and a hyaluronidase was purified and 
partially characterized from the venom of the snake Agkistrodon acutus by Xu et al. 
(1982), which was a glycoprotein with a M.W. of 33 kDa. Investigation of the M.W.s 
of a number of venom hyaluronidases using SDS-PAGE demonstrated that the venom 
samples from different animals - Dolichovespula maculata (whitefaced hornet), 
Yespula germanica (a yellow jacket), Pogonomyrmex rugosus (harvester ant), 
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Heloderma horridum horridum (Mexican beaded lizard), Heloderma suspectum 
suspectum (Gila monster), Lachesis muta (bushmaster snake), Crotalus basiliscus 
(Mexican west-coast rattlesnake), Bothrops riper (Central American pit viper), 
Micsurus nigrocinctus (a Central American coral snake) and Centruroides limpidus 
limpidus (Mexican west-coast scorpion) - contain the hyaluronidases. The 
hyaluronidases from all invertebrates are found to have smaller M.W.s (< 50 kDa) 
than those of vertebrates, which usually had M.W.s of over 60 kDa. The first marine 
source of hyaluronidase was reported by Poh et al. (1992), who purified a 
hyaluronidase with a pI of 9.2 and a M.W. of 62 kDa from the venom of stonefish 
(Synanceja horrida). A hyaluronidase from the white face hornet (Dolichovespula 
maculata) venom was identified by cloning and expression in bacteria (Lu et al., 
1995). As manifested by sequence comparisons, it was found to have 56% sequence 
identity with the honeybee venom hyaluronidase, and 27% identity with human sperm 
PH-20. A hyaluronidase from the venom of yellow jacket wasp (Vespula vulgaris) was 
also cloned and expressed, using the RACE PCR technique (King et al., 1996). 
Although a number of snake venom hyaluronidases were reported previously (Kudo 
and Tu, 2001; Kemparaju and Girish, 2006), no structural information had been given, 
except for a short 10-amino-acid N-terminal sequence provided by Girish et al. (2004), 
until Harrison et al. (2007) cloned the first snake venom hyaluronidase gene. The 
most studied hyaluronidase should be the one from the venom of honeybee (Apis 
mellifera), which was purified and partially sequenced by Kemeny et al. (1984). 
Based on this result, Gmachl and Kreil (1993) cloned its cDNA and found the 
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deduced protein to be homologous to the guinea pig sperm PH-20. The mature bee 
venom hyaluronidase has 349 amino acids containing three potential N-glycosylation 
sites. Following expression in E.coli, the recombinant protein was found to have 
retained the activity. The crystal structure of bee venom hyaluronidase, the only 
experimental structure available for hyaluronidase, was elucidated by Marković-
Housley et al. (2000). 
 
        Besides the bee venom hyaluronidases, a few hyaluronidases have also been 
identified in scorpion venoms. The isolation of this enzyme has been described 
previously in the venom of the scorpion Heterometrus fulvipes by Ramanaiah et al. 
(1990). Other scorpion hyaluronidases have been isolated and characterized from the 
venoms of Tityus serrulatus (Pessini et al., 2001) and Palamneus gravimanus (Morey, 
2006). Most recently, the first N-terminal sequence of the scorpion hyaluronidase 
from the Tityus stigmurus venom has been reported by Batista et al. (2007) through a 
proteomic investigation of the venom from scorpion. However, this ‘hyaluronidase’ 
enzyme has not been characterized and the sequence was found later to be dubious (to 
be addressed in “Discussion”). Before the present work, no full sequence has been 
revealed for the scorpion venom hyaluronidases, and their structures are totally 
unknown.  
 
        A summary on venom hyaluronidases is listed in Table 1.1. 
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1.8 Structures of hyaluronidases 
        A number of hyaluronidase protein sequences have been established. Of human 
origin, there are five hyaluronidase proteins: Hyaluronidase-1~-4 and PH-20, all of 
which have a high degree of homology. Sequence identities among the human 
hyaluronidases are from 33.1%, which is noted between the human Hyaluronidase-3 
and -4, to 41.2%, between the human Hyaluronidase-4 and human PH-20 (Jedrzejas 
and Stern, 2005). The structure of the hyaluronidase enzymes are tightly related to 
their function. Detailed studies have been conducted for the bee venom hyaluronidase 
(BVHYA) and bovine PH-20 (BPH-20). Both BVHYA and BPH-20 are globular 
proteins containing a large cleft which allows the binding of the substrate for catalysis. 
A classical distorted (β/α)7 triose phosphate isomerase (TIM) barrel fold, typically 
presenting in all the glycoside hydrolases of carbohydrate active enzyme family 56, is 
manifested in the structures of BVHYA and BPH-20. The clefts in these two 
hyaluronidases can accommodate the entire hexasaccharide fragment of hyaluronan. 
Negatively charged hyaluronan chains, which also have hydrophobic sugar ring 
surfaces, can readily bind to the cleft whose surface is lined with positive 
charged/hydrophobic amino acid residues for subsequent catalysis process (Fig.1.5.). 
H-donor catalytic Glu residue, which is encompassed by a number of positioning 
residues, is strictly conserved in all the known hyaluronidases. Glu113 in BVHYA and 
Glu149 in BPH-20, including the positioning residues are highly conserved, and any 
structural changes may lead to functional alterations. For example, removal of the 
Cys264 residue, one of the positioning residues of human hyaluronidase-4, may cause 
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 Table 1.1. Biochemical and biophysical properties of animal venom hyaluronidases (modified and updated from Kemparaju and Girish, 2006, 
to be continued on next page) 













Structural info. Ref. 
A. acutus (snake) 33 10.3 3.5~5.0 37 6.2; N.D. N.D. N.D. Xu et al.,1982 
A.contortrix contortrix   
                (snake) 
59.3 9 6 37 N.D. Tetrasaccharide N.D. Kudo and Tu, 2001 
N.naja isoform 1 70.4 9.2 5 37 N.D. Tetrasaccharide 10 a.a. of N-
terminal 
Girish et al., 2004 
           isofrom 2 
                (snake) 
52 9.7      
      
   
5 37 N.D. N.D. N.D. Girish and 
Kemparaju, 2005 
H.fulvipes (scorpion) 82 N.D. 4 N.D. N.D. N.D. N.D. Ramanaiah et 
al.,1990 
T.serrulatus(scorpion) 51 N.D. 
 
6 40 69.7; 3.3 
 
N.D. N.D. Pessini et al., 2001 
A.mellifera (bee) 41 9 6 37 N.D. Tetrasaccharide Full primary
and 3-D 
 Kemeny et al., 1984;  
Gmachl, and Kreil; 
1993;  Marković-
Housley et al.,2000 
S.horrida (fish) 62 9.2 6 37 709;13.1 N.D. Full primary Poh et al., 1992; Ng 
et al., 2005 
H.horridum horridum 
                 (lizard) 
63 5 5 Sensitive N.D. N.D. N.D. Tu and Hendon, 1983 
L.obliqua isoform1 49 N.D. 6~7 37 N.D. N.D. N.D. da C B Gouveia et 
al., 2005 
                isoform2 
                (caterpillar) 
53 N.D. 6~7 37 N.D. N.D. N.D. da C B Gouveia et 
al., 2005 
L.reclusa  isoform1 33 N.D. 5~6.6 37 N.D. N.D. N.D. Wright et al., 1973 
                isoform2 
                (spider) 
63 N.D. 5~6.6 37 N.D. N.D. N.D. Wright et al., 1973 
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Table 1.1.(continued) Biochemical and biophysical properties of animal venom hyaluronidases (modified and updated from Kemparaju and 
Girish, 2006)  














Structural info. Ref. 
Palamneus 
gravimanus(scorpion) 
52 N.D.       4.5 37 47.61;1.49 N.D. N.D. Morey et al., 2006
Tityus 
stigmurus(scorpion) 
44.8 N.D. N.D. N.D. N.D. N.D. 24 a.a. of N-
terminal  
Batista et al., 2007 
Echis ocellatus(snake) N.D.     
     
       
       
       
  
       
N.D. N.D. N.D. N.D. N.D. Full primary Harrison et al., 2007 
Potamotrygon motoro  
                     (fish) 
79 N.D. 4.2 40 4.91; 2.02* N.D. N.D. Magalhães et al., 2008 
Vitalius dubius      
                     (spider) 
45 N.D. N.D. N.D. N.D. N.D. N.D. Rocha-e-Silva et al.,
2009 
Loxosceles intermedia  
isoform 1   
41 N.D. 6~8 N.D. N.D. N.D. N.D. da Silveira et al., 2007 
                  isoform 2 
                    (spider) 
43 N.D. 6~8 N.D. N.D. N.D. N.D. da Silveira et al., 2007 
Hippasa partita   
                    (spider) 






4.5 50 95.3; 3.9 Tetrasaccharide Full primary Present work 
 
 







Table 1.2. Numbering scheme for conserved residues of the hyaluronidases involved in 
the catalytic process, and in essential positioning of the substrate’s carbonyl of the 
acetamido group for catalysis (Jedrzejas and Stern, 2005). The Cys263 residue of human 
hyaluronidase-4 interrupts the conserved scheme, which may reflect this human 
hyaluronidase-4’s specificity for chondroitin and its chondroitinase activity (Modified 
from Stern and Jedrzejas, 2006). HHYA-1~4: human hyaluronidase-1~4. 
Hyaluronidases BVHYA BPH-20 HHYA-1 HHYA-2 HHYA-3 HHYA-4
Catalytic residue Glu113 149 131 135 129 147 
Positioning residues Asp111 147 129 133 127 145 
 Tyr184 220 202 206 202 218 
 Tyr227 265 247 253 246 Cys263















(A) The X-ray structure of 
native BVHYA showing binding 
of the tetra-saccharide 
hyaluronan  to the surface of the 
enzyme within the cleft. The 
protein surface and the substrate 
hyaluronan are color-coded by 
atomic element. The color 
denotes: green-C, purple-N, red-












(B) The distorted (β/α)7 TIM 
barrel fold and the cleft are 
shown. The molecules (both 
enzyme and substrate) are color-
coded by the secondary 
structure elements (red-helices, 
yellow-β-sheets, green-other 
elements). The hyaluronan 
bound to the enzyme is located 
in the cleft (depicted in ball-




Fig.1.5. Tertiary structure of BVHYA with a hyaluronan tetrasaccharide (From Stern and 
Jedrzejas, 2005). Citation with permission by American Chemical Society (License 
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1.9 The biological and medical applications of hyaluronidases 
        With a view to use venoms as therapeutic potentials for medical applications, 
previous studies have focused more on the toxic components of the venom rather than on 
the non-toxic components like hyaluronidases (Kreil, 1995). As mentioned earlier 
(section 1.6), hyaluronidases, as well as the degraded hyaluronan fragments, have been 
shown to have interesting biological effects not only on anti-angiogenesis, cell 
invasion/motility and wound repair (Tempel et al.,2000; Sugahara et al., 2006; Dechert et 
al., 2006), but they are also known to play an important role in cancer chemotherapy of 
solid tumors. Application of hyaluronidase in chemotherapy may enhance the 
immunological control of the cancers by degradation of hyaluronan, especially for those 
cancers which are coated with abundant CD44-bound hyaluronan (Spruβ et al., 1995).  
 
        The significance and applications of hyaluronidase in cancer therapy has been long 
recognized by the biomedical reserachers and clinicians alike. In a number of pilot 
clinical studies, it was previously reported that the use of hyaluronidases as an adjunct to 
the conventional chemotherapy significantly improved the prognosis of most patients. In 
some cases, the supplemental treatment with the enzyme even induced significant 
responses in previously chemoresistant patients. (Beckenlehner et al., 1992; Smith et al., 
1997; Klocker et al., 1998). It was assumed that the degradation of hyaluronate-enriched 
ECM by the hyaluronidases might have facilitated the drug to readily exert its action on 
the target. Beckenlehner et al., (1992) studied hyaluronidase effect on the activity of 
adriamycin in breast cancer models both in vitro and in vivo. The activity of adriamycin 
was found to be significantly improved both in vitro and in vivo. It was speculated that 
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hyaluronidase facilitates the diffusion of adriamycin by making a hydrated space in the 
cells. Tumor growth was then indirectly inhibited by enhanced accessibility of the 
chemotherapeutic. It was also found by Shuster et al. (2002) that the exogenously added 
hyaluronidase repressed tumor growth via hydrolyzing the hyaluronan halo surrounding 
the tumor cells, and it was speculated that CD44 may be involved in this process. CD44 
is the cell-adhesion molecule widely distributed throughout the cell membrane that is 
involved in a number of biological events such as cell adhesion, cancer cell invasion and 
migration (Naor et al., 1997). CD44-hyaluronan interaction is important to cancer growth 
and progression (Platt and Szoka, 2008). The interfering of CD44-hyaluronan interaction 
by hyaluronidase, via disruption of hyaluronan matrix, has been found to effectively 
decrease the tumor growth (Shuster et al., 2002). Sy et al. (1992) reported that the soluble 
CD44-immunoglobulin fusion protein could suppress the tumor growth formed by human 
Burkitt lymphoma cells transfected with CD44. Zeng et al., (1998), on the other hand, 
demonstrated that the formation of tumor by B16F10 melanoma cells could be inhibited 
by hyaluronan oligomers. It is also likely that some tumors themselves may express 
hyaluronidase for their invasion (Udabage et al., 2005; Lokeshwar et al., 2005). It seems 
hyaluronidase can be both the promoter and suppressor for tumors. The role 
hyaluronidases play in cancer biology is still in question (Lokeshwar and Selzer, 2008).  
 
        Hyaluronidases may also show indirect effects by the degraded hyaluronan 
fragments, which are in fact polysaccharides in different sizes. The high M.W. 
hyaluronan fragments (>400 kDa) play a role in anti-angiogenic, anti-inflammatory and 
immunosuppressive, while the medium fragments (~20 kDa containing ~50 saccharide 
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units) can give rise to the synthesis of inflammatory cytokines. The low M.W. fragments 
(6~20 kDa), on the other hand, may stimulate the dendritic cells and antigen presenting 
cells in the immune system and may thus have an effect on angiogenic, inflammatory and 
immuno-stimulatory processes (Stern, 2005). Relatively smaller hyaluronan degradation 
fragments containing 3-10 disaccharides are also detected among the degradation 
products of hyaluronidases. This group of hyaluronan fragments inhibits anchorage-
independent growth of tumor cells. For instance, tetrasaccharides, the main products of 
human HYA-1, have anti-apoptotic activities, suppressing cell death in cultured cells 
undergoing hyperthermia or serum starvation (Stern, 2005). The high M.W. fragments are 
often present in normal biological process, while the low M.W. fragments show up 
frequently in cancers (Kumar et al., 1989; Lokeshwar et al., 1997). The fragments of 
hyaluronan play a role via interaction with the cell membrane receptors like CD44 and 
RHAMM. For example, proteolytic cleavage of CD44 by the low M.W. hyaluronan 
fragments can enhance the motility of tumor cells (Stern et al., 2006). 
     
1.10 Aims of the present study 
        The purpose of the present study is to investigate the high M.W. constituents of the 
venom from BmK, particularly the hyaluronidase enzyme, by purification, 
characterization, molecular cloning and expression, and to study its potential for medical 
applications.  
 
        The primary objectives of this study are: 
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1) To screen for the biological activities of BmK crude venom. The candidate activities 
include LAAO, serine protease, fibrinolytic, hemolytic, hyaluronidase and antibacterial.  
 
2) To purify and characterize the hyaluronidase from the venom of BmK.  
 
3) To describe and compare the enzyme characteristics. (i.e., optimal temperature, 
optimal pH, thermal stability, etc.), and to determine/analyze its N-terminal amino acid 
sequence, M.W. and final digestion product. 
 
4) To analyze the divergence and evolution of BmHYA1 through cloning and molecular 
characterization of its cDNA and comparison of BmHYA1 with other known 
hyaluronidase protein sequences, since it is supposed to be the first full protein sequence 
from scorpion species. 
 
5) To establish an E.coli expression system for production of the recombinant BmK 
hyaluronidase protein, in order to produce enough protein for future studies, e.g., 
functional and structural studies. 
 
6) To study the modulatory effects of BmK hyaluornidase on CD44 modulation in MDA-
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2.1 The venom 
        The lyophilized BmK crude venom (BCV) was bought from a supplier in 
Zhejiang Province, P.R. China. The animal was stimulated by an electric instrument 
and collected manually in a clean and chilled beaker. The wet venom was frozen and 
lyophilized after it was secreted. One gram of dried scorpion venom was obtained 
from about 3,000 scorpions. The lyophilized BCV was light yellow colored crystals. 
The crystals were weighed and dissolved in 0.05 M ammonium bicarbonate (pH 8.9), 
and then centrifuged at 50,000 ×g for 20 minutes to give a 100 mg/mL of BCV 
solution. The precipitated palette was removed and the suspended jelly-like materials 
were sieved by 0.2 µm filter. The transparent yellow solution, with the final protein 
concentration of 0.34 mg/mL, as determined by Bio-Rad protein assay kit (Hercules, 
CA, USA), was stored at 4 oC until use.  
 
2.2 Gel filtration of BCV and M.W. distribution of fractions  
        Gel filtration chromatography was used for the preliminary separation of BCV, 
as it separates the samples according to their M.W., which is apparent and in 
consistent with the previous basis for classifying the protein components in venoms, 
i.e., the M.W. - the high M.W. proteins and low M.W. peptides. The prepared BCV 
solution was loaded onto the Superdex G75 gel filtration column (Hi-load 16/60, 
Pharmacia Biotech, Uppsala, Sweden), and the venom fractions eluted with 50 mM 
ammonium bicarbonate, pH 8.9, at a flow rate of 1 mL/min. The absorbance was 
monitored at 280, 254, and 215 nm simultaneously. The protein concentration of 
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eluted fractions was determined by Bio-Rad protein assay kit (Hercules, CA, USA). 
The M.W. distribution was investigated by SDS-PAGE for high M.W. components, 
and mass spectrometry for low M.W. components. Subsequently, BCV and its 
respective fractions were tested for a variety of activities as follows.  
 
2.3 Screening of the biological activities of BCV and its gel filtration fractions 
        LAAO activity:   
        The assay was conducted in a 96-well microplate in triplicate. To initiate the 
reaction, 10 µL of crude venom solution and 90 µL of substrate solution were added 
into each well. The standard reaction mixture contained 5 mM of L-Leucine 
(substrate), 2 mM µ-phenylenediamine (OPD), 0.81 U/mL horseradish peroxidase 
(HRP) and either the test venom solution or the snake Naja Kaouthia crude venom 
solution (positive control) as LAAO source, in a total volume of 100 µL/well of 50 
mM Tris–HCl buffer (pH 8.0). For negative control, 50 mM ammonium bicarbonate, 
pH 8.9 was added into the well in place of the sample or standard LAAO. After 
incubation at 37 oC for 60 minutes, the reaction was terminated by adding 50 µL of 2 
M H2SO4. The absorbance of the reaction mixture was measured at 450 nm 
(Kishimoto and Takahashi, 2001).  
 
        Fibrinogenolytic activity:  
        Fibrinogenolytic activity was measured as follows: samples (from 10 peak 
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fractions) and human fibrinogen (5 mg/mL) dissolved in 50 mM Tris–HCl buffer, pH 
7.4, containing 0.1 M NaCl and 10 mM CaCl2, were incubated at 37 oC for 16 hours. 
After the incubation, 20 µL of the reaction mixture was transferred into a small test 
tube, to which 20 µL of the solution containing 1% sodium dodecyl sulfate (SDS) and 
2% β-mercaptoethanol was added. The resultant solutions were loaded onto 15% 
SDS-PAGE gel. The degradation of the fibrinogen chains indicated the existence of 
the activity (Gao et al. 1998).  
 
        Hemolytic activity 
        Hemolytic activity was assayed on citrated rat blood and washed erythrocytes 
(Gao et al, 1999). One hundred and ninety ul of erythrocyte suspension (washed for 
three times with 20 mM Tris–HCl, pH 7.4, containing 1 mM CaCl2 and 0.9% NaCl 
and resuspended for 10 times with the same buffer) were incubated with the samples 
(10 µL) at 37 oC for 30 minutes. The degree of hemolysis was determined as the 
percentage of hemoglobin released (measured at 540 nm) by the toxin compared with 
a 100% hemolysis produced by the addition of 1% Triton X-100. For the whole blood, 
no washing was performed, and the blood (collected in 3.8% sodium citrate, 1:9, v/v) 
was directly added with the samples and incubated at 37 oC for 30 minutes. Positive 
control (containing 1% Triton X-100) was the same as that used for the erythrocyte 
test. Ammonium bicarbonate (50 mM, pH 8.9) buffer alone without the samples was 
used as a negative control.  
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        Antibacterial activity: 
        Antibacterial activity was assayed by the method of agar-well diffusion assay 
(Mathabe et al., 2006) with modification, by observing the growth inhibition of 
Escherichia coli DH5α. The agar plates were prepared by pouring approximately 15 
mL of molten media (1% Tryptone, 0.5% yeast extract, 1% sodium chloride and 1.5% 
agar, all from Sigma, St. Louis, MO, USA) into sterile petriplates (diameter=90 mm, 
Sterilin, Middlesex, UK), which were allowed to solidify for 20 minutes. The 
inoculum suspension of E. coli (100 µl in frozen glycerol stock, for preparation see 
section 2.6.4.3) was swabbed uniformly on the agar plates, and the inoculum was 
allowed to dry for 5 minutes. Since it is only a preliminary screening test, instead of 
making a well in the agar, the samples (i.e., BCV and its fractions) at various 
quantities (10 µg~ 1000 µg), were put directly on the bacterial colonies in pre-
determined regions on the agar when the inoculum was dried. The plate was then put 
into 37 oC incubator overnight. If the bacterial growth was inhibited, no bacteria 
would grow on the agar where the sample was applied. The antibacterial activity was 
shown as a round inhibition zone appearing on the agar.  
 
        Amidolytic activity: 
        Amidolytic activity assay was followed by the method of Zhang et al.(1998b). 
Chromogenic substrate S-2238 (d-Phe-(pipecolyl)-Arg-p-nitroaniline hydrochloride) 
was used for the test. Assays were performed in 50 mM Tris–HCl, pH 7.8, 0.01% 
Tween-80 in a total volume of 500 µL. The reaction was launched by the addition of 
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the sample and the formation of p-nitroanilide (pNA) was monitored continuously at 
405 nm. The amount of substrate hydrolyzed was calculated from the absorbance at 
405 nm by using a molar extinction coefficient of 10,000 M−1 cm−1 for free pNA.  
        PLA2 activity:  
        The PLA2 activity was assayed using Secretory Phospholipase A2 Assay Kit 
(Cayman Chemical, Ann Arbor, MI, USA). sPLA2 activity was tested in alternate 
fractions collected from tubes 41 to 79 (mL). Ten microliters of elution fractions were 
added to the wells together with 10 µL of DTNB and 5 µL of assay buffer (both 
provided by the kit). The reaction was initiated by adding 200 µL of substrate. 
∆A405/min was determined and sPLA2 activity (µmol*min-1*mL-1) was calculated 
using the formula indicated in the manual. 
        Hyaluronidase:  
        Hyaluronidase enzyme activity was determined turbidometrically by the method 
of Poh et al. (1992). Hyaluronic acid (0.5 mg/mL in 0.05 M acetate buffer, pH 4.5, 
containing 0.15 M NaCl) was incubated with the test solution for 15 minutes at 37 oC 
(final volume 0.5 mL) and the reaction was stopped by the addition of 1 mL of 2.5% 
(w/v) hexadecyltrimethylammonium bromide in 2% (w/v) NaOH. The absorbance of 
each reaction mixture was read at 400 nm. Turbidity reducing activity was expressed 
as the percentage of the remaining hyaluronan. The absorbance was taken as 100% in 
which no enzyme was added. Turbidity reducing units are expressed as the amount of 
enzyme needed to hydrolyze 50% of 50 µg hyaluronic acid. One unit was defined as 
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the amount of enzyme that would cause the same turbidity reduction as 1.0 unit of 
international standard preparation. The blank consisted of one volume of acetate 
buffer (0.05 M acetate buffer, pH 4.5, containing 0.15 M NaCl) and two volumes of 
stop solution. 
 
2.4 The purification of BmHYA1 
        2.4.1 Gel filtration  
        The crude venom was initially subjected to gel filtration chromatography as 
described in section 2.2. 
 
        2.4.2 Anion exchange chromatography 
        The pooled fractions collected in the previous step were applied on UNOQ1 
anion exchange column (7×35 mm, Bio-Rad, Hercules, CA, USA) pre-equilibrated 
with 50 mM NH4HCO3 buffer, pH 8.9. The samples were eluted with a 0 ~ 40% 1 M 
NaCl gradient, at a flow rate of 1.5 mL/min. The purification process was monitored 
at the absorbance of 215 nm. The eluted fractions with hyaluronidase activity were 
pooled and lyophilized for further purification. 
 
        2.4.3 Cation exchange chromatography 
        The lyophilized pooled fraction was then loaded onto the UNOS1 cation 
exchange column (7×35 mm, Bio-Rad, Hercules, CA, USA). The column was 
equilibrated with 50 mM sodium acetate, pH 5.0, and the fractions eluted by applying 
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an increasing gradient of 0 to 100% NaCl, at a flow rate of 1.5 mL/min. The 
purification process was monitored at the absorbance of 215 nm. 
 
        2.4.4 RP-HPLC 
        For final purification of the target enzyme, the RP-HPLC C8 column, pre-
equilibrated with 0.1% TFA, was used at a flow rate of 0.5 mL/min. The purification 
process was monitored at the absorbance of 215 nm. The increasing gradient of 
acetonitrile was applied to elute the target protein, which displayed a single peak upon 
elution, and later verified to have the hyaluronidase activity in the enzyme assay. 
 
2.5 Characterization of BmHYA1  
        2.5.1 SDS-PAGE 
        Vertical SDS-PAGE gel electrophoresis is a widely-used technique for analyzing 
protein molecules. Liquid acrylamide molecules polymerized and form a net-like gel 
when solidified. Under an electric field, protein which carries negative-charged SDS 
molecules, will migrate towards the positive electrode. The smaller of the protein 
molecule, the faster it can move. In this experiment, SDS-PAGE mini gel was used for 
confirmation of the homogeneity of the enzyme and estimation of its M.W.. The 
sample obtained from the final chromatographic (RP-HPLC) step was subjected to 
12% SDS-PAGE gel with Tris-Glycine buffer at pH 8.8 as a running buffer. The gel 
was then developed in a suitable volume of GelCode Blue Stain Reagent (Thermo 
Scientific, Waltham, MA, USA) for 1 hour and washed with MilliQ water.   
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        2.5.2 Mass spectrometry 
        MALDI-TOF MS is a common and sensitive way to determine the precise M.W. 
of proteins and peptides. The measurement was carried out at the Protein and 
Proteomics centre, National University of Singapore, by MALDI-TOF (ABI 4700 
linear mode) mass spectrometry.  
 
        2.5.3 N-terminal sequencing 
        The technique for the determination of protein N-terminal amino acid sequence, 
as developed by Edman (Edman, 1950), is involved in a phenylisothiocyanate (cyclic) 
degradation procedure. Amino acid residues are cleaved once a time from the N-
terminal of the protein and identified as the phenylthiohydantion derivatives. ABI 
Procise 494 Protein Sequencer at the Protein and Proteomics Centre of Department of 
Biological Science, National University of Singapore, was used to conduct Edman 
degradation to determine the N-terminal sequence of the purified enzyme. 
 
        2.5.4 Optimal pH and temperature 
        Suitable amounts of the enzyme were used for examining the relative activity 
under various conditions. The maximum activity was set as 100% and other degrees 
of activity were expressed as different percentages compared with the maximum one. 
Different buffer systems - citrate buffer for pH 3 and below, acetate buffers for pH 4-6, 
phosphate buffer for pH 7 and Tris-HCl buffers for pH 8 and above - were used to 
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study the optimal pH. In another series of experiments, various temperature settings – 
4, 24 (room temperature), 37, 45, 50, 55, 60, 70 and 80 oC – were used to study the 
temperature effect. The amount of each of the three enzymes (BmHYA1, bovine 
testicular hyaluronidase and Daboia russelii snake venom hyaluronidase) was 
adjusted to degrade approximately 50% of the hyaluronan (25 µg) in 15 minutes at 37 
oC.The reaction buffer was 50 mM sodium acetate pH 4.5.  
 
        2.5.5 Thermostability  
        The stability of the enzyme with respect to temperature was measured by the 
method of Zaneveld et al.(1973). The hyaluronidase was pre-incubated at different 
temperatures for 10 minutes in a test tube, and then immediately cooled in tap water 
before incubating the tube (containing the whole reaction system, see section 2.3: 
Hyaluronidase) in a 37 oC water bath for 15 minutes. 
 
        2.5.6 Km and Vmax determination 
        Km and Vmax are two terms involved in enzyme kinetics. Km denotes 1) the 
affinity of substrate to the enzyme and 2) the rate at which the complex converts to 
the product after enzyme-substrate binding. Vmax refers to the maximum initial 
velocity of the enzyme catalyzed reaction under a given condition, which occurs when 
the enzyme is saturated by the substrate (i.e., the enzymatic sites are all occupied by 
the substrate). Both of the two constants cannot be measured directly. The Michaelis-
Menten equation can be used to calculate the two parameters. The determination of 
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Km and Vmax was by the method of Poh et al. (1992) with modification. The amount of 
hyaluronidase was adjusted to hydrolyze 50% of 50 µg hyaluronan in 15 minutes 
under 37 oC and at pH 4.5. Under the same condition, the increasing amounts of the 
hyaluronan (10~35 µg) were added into the reaction system for incubation. The 
velocity of the hydrolysis was expressed by the hyaluronan deposition at microgram 
level. 
 
        2.5.7 Deglycosylation of BmHYA1  
        Deglycosylation test was performed using Enzymatic Protein Deglycosylation 
Kit (Sigma, St. Louis, MO, USA), in order to study the glycosylation type of 
BmHYA1. Thirty micrograms of BmHYA1 was dissolved in 30 µL of deionized 
water in an Eppendorf tube. Ten microliters of 5X Reaction Buffer and 2.5 µL of 
Denaturation Solution were added, following which the solution was gently mixed 
and heated at 100 °C for 5 minutes. After the reaction system was cooled to room 
temperature, TRITON X-100 solution (2.5 µL) was added, followed by addition of 1 
µL each of the PNGase F, O-Glycosidase, and α-2(3,6,8,9) Neuraminidase. The 
reaction solution was then incubated for 24 hours at 37 °C. The result was analyzed 
by 15% SDS-PAGE. The deglycosylated protein had relatively low M.W. and would 
shift to a lower position. According to the product manual, PNGase F cleaves most 
asparagine-linked complex, hybrid, or high mannose oligosaccharides; α-2(3,6,8,9) 
Neuraminutesidase cleaves all non-reducing terminutesal branched and unbranched 
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sialic acids; and O-Glycosidase cleaves serine or threonine-linked unsubstituted Gal-
β(1-3)-GalNAc-α−.  
 
        2.5.8 Effect of inhibitors on hyaluronidase activity 
        The hyaluronidase concentration was adjusted to the extent that the turbidity was 
reduced to 10% of the original. The hyaluronidase potential inhibitors, i.e., Mg2+, Ca2+, 
Cu2+, Fe3+, reduced glutathione, L-cysteine, DTT, EDTA and heparin, were assayed for 
their inhibitory activity. They were pre-incubated with the enzyme for 15 minutes at 4 
oC. Then the hyaluronan was added to initiate the reaction at 37 oC for 15 minutes. 
Control experiments were carried out with no inhibitors added or the inhibitors added 
only immediately before the measurement to counteract the color caused by the 
inhibitors themselves.  
 
        2.5.9 Thin-layer chromatography (TLC) for determination of the final 
digestion product  
        TLC is a kind of chromatography to separate the mixed samples in a thin layer of 
adsorbent material, which was the silica gel in this experiment. The resultant digestion 
samples contained high concentration salt and therefore could not be applied directly 
to MS to test their M.W.. A method of (Kudo and Tu, 2001) with modification was 
used for analyzing the final digestion product of hyaluronan by BmHYA1 and bovine 
testicular hyaluronidase. The digestion product of hyaluronan by bovine testicular 
hyaluronidase, which is known to produce tetrasaccharides (Kudo and Tu, 2001), was 
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used as a marker for molecular size comparison. Two hundred micrograms of 
substrate and 700 units of enzymes were mixed in 50 mM sodium acetate buffer 
(containing 0.15 M sodium chloride), pH 4.5 (final volume 100 µL). The mixture was 
incubated at 37 oC for 24 hours. 
 
        The digestion products were separated by TLC using a pre-coated silica gel 
Kieselgel 60 (aluminium plate, 5×10cm, Merck, Darmstadt, Germany). Isopropanol: 
water (66:34) with 0.05 M sodium chloride was used for TLC development. The 
oligosaccharides were detected by spraying the plate with 0.5% (w/v) orcinol in 10% 
H2SO4 and heating at 120 oC. 
 
2.6. BmHYA1 cloning and expression 
        2.6.1 Total RNA extraction 
        A pair of BmK venom glands from a single scorpion was flash frozen in liquid 
nitrogen before being transferred to –70 oC until use. RNeasy mini Kit (Qiagen, Venlo, 
The Netherlands) was employed for the extraction of total RNA from the venom 
glands.  
 
          The experimental procedures were as follows: 
          1)  The gland tissue with an estimated weight of 20 mg was taken out from –70 
oC and put into liquid nitrogen. It was pulverized with clean mortar and pestle in 
liquid nitrogen. Liquid nitrogen was added from time to time during the operation 
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process to prevent it from drying out. Seven hundred microliters of buffer RLT 
(containing guanidine thiocyanate) with 0.1% β-mercaptoethanol was added into the 
mortar immediately after the liquid nitrogen was evaporated. The frozen sample 
blocks were then crushed with a pestle and the suspension was transferred with a 
Pasteur pipette into a clean 2 mL Eppendorf tube. The pulverized tissue was further 
homogenized in the tube by homogenizer.  
        
          2) The tube containing the sample was centrifuged at 16,000 ×g for 3 minutes. 
The supernatant (~ 600 µL) was transferred to a new 1.5 mL tube and then thoroughly 
mixed by pipetting with 600 µL 70% ethanol (1:1). The mixture was applied 
successively (maximum 700 µL per time) to a RNeasy mini column by placing it in a 
2 mL collection tube followed by centrifugation at 16,000 ×g for 15 seconds. The 
flow-through was discarded.  
 
          3) Seven hundred microliters of buffer RW1 was added to the column 
subsequently and centrifuged at 16,000 ×g for 15 seconds. The flow-through was 
discarded. 
 
a. The column was transferred to a new collection tube, washed with 
500 µL Buffer RPE by centrifuging at 16,000 ×g for 15 seconds, 
and the flow-through was discarded. This step was repeated by 
centrifuging for 2 minutes. 
 45
Chapter 2: Materials and Methods 
 
b. The column was transferred to a new, clean 1.5 mL tube. Thirty 
microliters of RNase-free water was directly put onto the RNeasy 
silica-gel membrane in the column. After 1 minute incubation at 
room temperature, total RNA was released to the bottom of the 
tube by centrifuging the column at 16,000 ×g for 1 minute. 
 
          4) Quality test of the RNA sample 
          Since the quality of the starting materials is critical for the molecular work, 
RNA sample was tested for its quality, including concentration, purity and integrity, 
before further processing.  
 
   i) Quantitation and purity determination 
        The concentration and the purity of the RNA sample were tested by Nanodrop 
(Thermo Scientific, Wilmington, DE, USA). RNA concentration was considered as 40 
µg/mL when A260 value was 1. Sample with A260/280 ratio of ~ 2 was considered as 
a pure RNA. Two microliters of the sample was applied onto the machine and the 
result was automatically recorded. 
 
  ii) Integrity test 
         RNA sample is readily degraded by the RNase, which spreads broadly in animal 
tissues and the environment. Horizontal agarose gel electrophoresis was used to test 
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the integrity. RNA sample was run in 1% agarose gel for 40 minutes at 110 V using 
buffer TAE. Agarose gel was stained later by Golden SYBR staining solution for 30 
minutes. The working solution was prepared freshly before use by diluting the SYBR 
Gold (5000X) solution that was stored in the dark. The band was detected under UV 
illuminator. Sample with clear 28S and 18S bands and without smear area under these 
two bands indicated the integrity of RNA sample. 
 
        2.6.2 First strand cDNA synthesis from Total RNA 
        First strand cDNA synthesis was accomplished by reverse transcription 
polymerase chain reaction (RT-PCR), using SuperScript™ II Reverse Transcriptase 
(SuperScript™ II RT) (Invitrogen, Carlsbad, CA, USA). Following this step, RNA 
template was degraded from cDNA:RNA hybrid molecule by RNase H.  
   
        Three microliters of total RNA (approximately 250 ng) was used to convert to 
cDNA. The procedures were according to the 3’ RACE system manual provided along 
with the kit (Invitrogen, Carlsbad, CA, USA). Briefly, RNA was mixed with 1 µL of 
10 µM Adapter Primer (AP, 5’-GGC CAC GCG TCG ACT AGT AC(T)17-3’). AP 
takes the advantage of poly A+ tail of mRNA and contains extra nucleotide sequences 
to facilitate the later restriction enzyme-based molecular work. The mixture of RNA 
and AP was added with RNase free water to the final volume of 12 µL. The solution 
was incubated at 70 oC for 10 minutes and chilled on ice for 1 minute. Following 
components were then added to the reaction system:  
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10X PCR buffer              2 µL 
25 mM MgCl2                 2 µL 
10 mM dNTP mix           1 µL 
0.1 M DTT                   2 µL 
The solution was equilibrated at 42 oC for 5 minutes before 1 µL SuperScript™ 
II RT was added. The system was kept at 42 oC for 50 minutes for the reaction, which 
was terminated by 15 minutes of incubation at 72 oC. One microliter of RNase H was 
added to the system (37 oC, 20 minutes) to degrade RNA template after the system 
was chilled on ice. 
The product, i.e., single-stranded cDNA (ss cDNA), was stored at –20 oC for 
future amplification. 
 
        2.6.3 3’ rapid amplification of cDNA ends (3’-RACE) 
        3’ RACE is a technique to amplify the unknown DNA sequences using cDNA as 
a template and by taking the advantage of the natural poly A tail of the mRNA. When 
appropriate gene specific primer (GSP) at 5 prime and a universal amplification 
primer (UAP) was applied, the sequence in between would be amplified with a PCR 
program. In present work, the 3’ RACE experiment was conducted basically using the 
Invitrogen 3’RACE system (Invitrogen, Carlsbad, CA, USA). 
 
  2.6.3.1 Design of degenerate GSP 
  Degenerate primer can be designed based on a known amino acid sequence or 
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an amino acid sequence alignment. Amino acid sequence was reverse-translated to 
nucleotide sequence. Because of the degeneracy of the genetic code, in most cases it 
is impracticable to deduce the exactly nucleotide sequence from the known protein 
sequence. Then the primer would be a pool containing many possible sequences and 
thus the degenerate primer was actually a mixture. But too many primers mixed 
together would significantly reduce the specificity and even fail to prime the 
amplification. In addition, 3’ end of the primer should be no degeneracy to avoid the 
unspecific extension. To balance up, the degenerate primer would be no more than 
100 degeneracy and relatively short (17~23 bases) and no degeneracy at 3 prime (Pan 
et al., 2007). In this experiment, degenerate BmHAY1-GSP was designed based on 
the known segment of N-terminal amino acids of BmHYA1 (D-F-K-V-V-W-E), as 5’-
GAY TTY AAR GTI GTN TGG GA-3’, where I was Inosine, which was used for the 
substitution of all the four nucleotides A/C/T/G, therefore it reduces the degeneracy of 
the primer pool of 4-fold and N for A+C+T+G, Y for C+T, R for A+G, respectively. 
The primer was finally made as a degeneracy of 32, length of 20 bases and no 
degeneracy at 3’ end. AUAP (5’- GGC CAC GCG TCG ACT AGT AC - 3’) was 
provided by the commercial supplier. It contains the RE site sequence homologous to 
the adapter region of the AP. The fragment between these two segments was amplified, 
cloned and sequenced. 
 
          2.6.3.2 Amplification of 3’ end cDNA of BmHYA1 with PCR 
  Polymerase chain reaction (PCR) was used for the 3’ end amplification of 
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cDNA encoding BmHAY1 from BmK venom ss cDNA library. The amplification was 
primed by the two oligonucleotides, BmHYA1-GSP and AUAP. BmHYA1-GSP was 
used as sense primer and AUAP for anti-sense. 
 
  The following components were added orderly into a clean PCR tube (50µL 
reaction system): 
10X PCR buffer                                    5 µL 
25 mM MgCl2                                    3 µL 
Autoclaved Milli Q water                      36.5 µL 
10 mM dNTP mix                           1 µL 
BmHAY1-GSP  (100 µM solution)       1 µL 
AUAP (10 µM)                            1 µL 
Taq DNA polymerase (5 units/µL)         0.5 µL 
cDNA solution                             2 µL 
 
          A PCR instrument was used to perform the typical PCR (Eppendorf, 
Mastercycler Gradient, Eppendorf Scientific, Westbury, NY, USA). To prevent 
evaporation, the lid temperature was set to 94 oC. Thirty four cycles were carried out 
beginning with 2 minutes of denaturing at 94 oC and ending by an extension step at 72 
oC for 7 minutes.  
 
  The PCR program was performed as follows: 
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94 oC        2 minutes                1 cycle 
94 oC        1 minute 
50 oC        1 minute 
72 oC        2.5 minutes             32 cycles 
72 oC        7 minutes                1 cycle 
 
          The PCR program was performed with a relatively low annealing temperature 
of 50 oC. The degenerate primer was a mixture of various primers; the lower 
annealing temperature was set to facilitate the binding between primer and template. 
Together with this PCR, three other PCRs were carried out for control or alternative 
trial, which were primed by: rat GAPDH primer (5'-CCT TCA TTG ACC TCA ACT 
AC-3') and AUAP (as control), BmKAS-1 primer (5’- GTC TGT TCA TTT GTG 
CTG ATA GGA G-3’) and AUAP (as control), and hyaluronidase universal primer 
based on conserved region (SFHYA1-GSP, 5’- GSI GTI ATY GAY WKI GA-3', Ng et 
al., 2005) and AUAP (as alternative trial), respectively. All of the four PCRs were 
conducted simultaneously. After the reaction, five microliters of the PCR products of 
each reaction were applied to 1.5% agarose gel electrophoresis and stained by SYBR 
gold (Invitrogen, Carlsbad, CA, USA) for detection. 
 
          2.6.3.3 Agarose gel electrophoresis 
          Horizontal agarose gel electrophoresis is a widely-used technique to analyze 
DNA by their sizes. The fragments of DNA can migrate through agarose gel under an 
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electric field. DNA molecules, which bear negative charge, will migrate towards the 
positive electrode. DNA molecules of smaller size move faster than the larger ones. 
The result is visualized by SYBR Gold staining under UV light. In the experiment, the 
electrophoresis instrument was from Bio-Rad (Hercules, CA, USA), agarose gel 
powder was from Seakem LE (Bioproducts, Rockland, Maine, USA), 6X loading dye 
was from Promega (Madison, WI, USA), TAE buffer was supplied by the National 
University Medical Institutes, National University of Singapore. The experiment 
condition was 40 minutes at 110 V. Gels were stained with SYBR Gold for 30 minutes 
before being examined under UV light.  
 
          2.6.3.4 Isolation of DNA from agarose gel  
          DNA was isolated with QIA gel extraction kit (Qiagen, Venlo, Netherlands). 
The target DNA band was excised from agarose gel under UV illuminator with a 
clean scalpel and put into a clean 1.5 mL tube. Buffer QG was added into the tube 
(VQG:Vgel=5:1) to dissolve the gel. The tube was incubated at room temperature until 
the gel was dissolved in the buffer (usually less than 1 hour). The solution was then 
applied into a QIA quick spin column, which was attached to a collection tube and 
centrifuged at 16,000 ×g for 1 minute. The solution in the collection tube was 
discarded. The column was washed with 0.75 mL of buffer PE (with 75% ethanol) for 
30 seconds and then placed into a new 1.5 mL tube. The bound DNA was eluted by 
addition of 30 µL elution buffer (provided in the kit) to the center of the spin column 
matrix followed by a centrifugation at 16,000 ×g for 1 minute. 
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        2.6.4 Enzymatic manipulation of DNA 
        All the restriction enzymes and buffers were from Promega (Madison, WI, USA). 
The enzymes involved were EcoR I, BamH I, Xho I and T4 DNA ligase.   
     
          2.6.4.1 DNA ligation 
          pGEM-T Easy cloning kit (Promega, Madison, WI, USA) was employed for 
DNA ligation. In PCR, Taq polymerase may add a 3’-A overhang to both ends of the 
PCR product; the T-vector with 3’-T overhang at each end can connect to A and allow 
the fragment to ligate with the vector forming a recombinant plasmid. The connection 
was accomplished with T4 DNA ligase. A typical 10 µL ligation of cohesive ended TA 
cloning reaction system was composed as follows:  
 
        Vector DNA                                             1 µL (25 ng/mL) 
        Insert DNA                                              3 µL 
        2X ligase buffer                                       5 µL 
        T4 DNA ligase                                         1 µL (1 unit) 
    
    To obtain the maximum ligation efficiency, the reaction was carried out at 4 oC 
overnight and the reaction product was stored at -20 oC until use. 
 
          2.6.4.2 DNA digestion  
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          The analytical restriction enzyme reaction was performed in a volume of 20 µL 
as follows: 
        Sterile, nuclease-free water                 5 µL 
        Restriction enzyme 10X buffer              2 µL 
        BSA, Acetylated (1 mg/mL)                 2 µL 
        DNA sample                                           10 µL 
        Restriction enzyme                                  1 µL 
        The reaction system was incubated overnight at 37 oC to achieve complete 
digestion. 
  
          2.6.4.3 Heat shock transformation and white/blue screening 
 
           i) Preparation of competent cells 
          The original DH5α competent cells were streaked on an antibiotic-free agar 
plate and incubated at 37 oC overnight. One single clone was taken and the cells 
grown at 37 oC with vigorous shaking to reach optical density (OD) 600 of 0.4-0.5 
(mid log phase of cell growth, 1 cm path length). The cells were chilled on ice for 20 
minutes before centrifugation (2,500 ×g, 15 minutes at 4 oC). The cell pellet was re-
suspended with autoclaved ice-cold 0.1 M CaCl2 (10 mL/50 mL of the culture). The 
cells were again centrifuged, 2,500 ×g, 15 minutes at 4 oC and the final cell pellet was 
re-suspended with ice-cold 10% glycerol in autoclaved 0.1 M CaCl2 solution (2 
mL/50 mL original culture). The DH5α competent cell suspension was aliquoted in 
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100 µL volumes and stored at -70 oC till use.  
 
      ii) Heat shock transformation of bacterial cells and white/blue screening 
          The stored DH5α was taken out from -70 oC and thawed on ice for 5 minutes. 
Five microliters of the ligation mixture was added to the cells and mixed by tapping 
the tube gently. The mixture was kept on ice for 20 minutes. The tube was then put in 
42 oC water bath for exactly 45 seconds followed by immediate chilling on ice for 2 
minutes. The cell suspension was transferred to a test tube with 400 µL of super 
optimal broth (SOC) medium and placed at 37 oC for 30 minutes to 1 hour with 
shaking. Meanwhile, 100 µL Isopropyl β-D-thiogalactopyranoside (IPTG, 100 mM) 
and 20 µL X-gal (40 mg/L) were spread onto an ampicillin-positive cultural plate. The 
cell suspension was subsequently plated evenly. The plate was then incubated 
overnight at 37 oC for the transformants to grow. This blue and white screening helps 
to detect the successful ligation in the transformants. The white clones were supposed 
to be the positive transformants. White colonies were picked up and transferred into 2 
mL of lysogeny broth (LB) medium (with 50 µg/mL ampicillin) in a loosely capped 
10 mL tube and incubated at 37 oC with vigorous shaking (220 rpm) for 14-16 hours.  
 
          2.6.4.4 Isolation of plasmids from the bacteria 
          To isolate plasmids from the bacteria, GE illustra™ plasmid Prep Mini Spin Kit 
(Piscataway, NJ, USA) was employed. The isolation was performed according to the 
manual, containing alkaline cell lysis and silica-based membrane binding and washing 
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procedures. Briefly, the bacteria suspension was harvested by centrifuge at high speed 
(16,000 ×g, 30 s). The supernatant was discarded and the bacteria pallet was re-
suspended by isotonic solution containing RNase A (Solution I). Solution II (alkali 
buffer) was added subsequently to lyse the cells and the genomic DNA and proteins 
were denatured. The resultant solution was naturalized by Solution III, which is an 
acetate buffer and containing chaotropic salt. With centrifuge (16,000 ×g, 4 minutes), 
the unwanted components in the lysate, including genomic DNA, proteins and lipids, 
were precipitated. The supernatant containing plasmids was collected and transferred 
to column with a silica membrane. The membrane can retain the plasmid DNA. After 
a washing step, the plasmid DNA was eluted with an elution buffer. 
 
          2.6.4.5 Verification of the insert fragment  
          The verification of the insert is necessary before applying to DNA sequencing 
to avoid any false positive or non-specific insert. Two methods were used for this test.  
     
          i) Restriction enzyme digestion 
          The vector of pGEM contains restriction site of 5’-gaattc-3’ for EcorR I enzyme, 
which flank the cloning site. Digestion of EcorR I would release the insert from the 
vector. EcorR I enzyme package (Promega, Madison, WI, USA) was hence used for 
this test. The reactions were conducted as described in section 2.6.4.2. The plasmids 
containing the insert of expected sizes were sent for sequencing.  
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          ii) PCR with T7 and SP6 primers 
          The vector of pGEM-T Easy contains T7 and SP6 promoter sequences at 
upstream and downstream respectively of the cloning site. After 14-16 hours of 
shaking, a small volume (0.5~1 µL) of LB medium which had considerable bacteria 
could be used as the template because it was supposed to contain the plasmid. The 
plasmid would be released at 94 oC and served as the template. With T7 and SP6 
primers, the insert would be amplified by a PCR program. The PCR products would 
be examined by electrophoresis. The bacteria tubes which were tested to contain 
expected plasmids/inserts were proceed to plasmid isolation and DNA sequencing. 
 
          2.6.4.6 DNA sequencing 
          DNA sequencing was accomplished commercially, by 1st-Base Singapore.   
Plasmids (10 µL, 100 µg/mL) were sent for sequencing directly. Primers M13 
Forward/Reverse, T7 promoter, S·tag coding sequence, T7 terminator and specific 
internal primers were chosen for different DNA samples.  
 
        2.6.5 Protein sequence analyzing 
        The mature protein was deduced by the nucleotide sequence. A number of 
hyaluronidases were aligned by Cluster W method (Thompson et al., 1994), using 
Lasergene software (DNASTAR, Madison, WI, USA). The sequence comparison 
included 9 hyaluronidases: BmHYA1 (present work), honeybee venom HYA 
(honeybee venom hyaluronidase, AAA27730.1), SFHYA1 (stonefish venom 
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hyaluronidase, AAO74499.1), Snake Eo HYA (snake E. ocellatus venom 
hyaluronidase, ABI33937.1), HYAL1~4 (human hyaluronidases 1~4, CAG46731.1, 
NP_149348.2, NP_003540.2, NP_036401.2), Human PH-20 (AAC60607.2). To 
determine diversification of the hyaluronidase enzymes, phylogenetic analysis was 
employed. A neighbor-joining method was used to construct the phylogenetic tree 
implemented by MegAlign, in Lasergene software (DNASTAR, Madison, WI, USA). 
Twenty-seven hyaluronidases were selected for phylogenetic analysis, including both 
venom and non-venom hyaluronidases, they are: BmHYA1 (present work), C. elegans 
hyaluronidase (CAA88874.1), sand fly hyaluronidase (AAD32195.1), honeybee (Apis 
mellifera) venom hyaluronidase (AAA27730.1), paper wasp hyaluronidase 
(AAD52616.1), white-face hornet hyaluronidase (AAA68279.1), yellow jacket wasp 
hyaluronidase (AAB48073.1), solitary wasp A. samariensis (BAF93867.1), mouse 
serum hyaluronidase (AAC15949.1), human HYAL-1~4 (CAG46731.1, NP_149348.2, 
NP_003540.2, NP_036401.2),  snake C. cerastes venom hyaluronidase (ABI33940.1), 
snake E. ocellatus venom hyaluronidase (ABI33937.1), snake B.arietans venom 
hyaluronidase (ABI33945.1), rat hyaluronidase (AAD01980.1), mouse HYAL2 
(AAK28481.1), SFHYA1 (stone fish venom hyaluronidase, AY232496), xenopus 
kidney hyaluronidase (AAD28281.1), rat sperm surface antigen, 2B1 (CAA62016.1), 
red fox PH-20 (AAB86588.1), cynomolgus monkey M.fascicularis PH-20 (L13780), 
mouse PH-20 (BAC55070.1), human PH-20 (AAC60607.2), rabbit PH-20 
(AAA88913.1) and Guinea pig PH-20 (CAA39768.1). 
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        2.6.6 Expression of BmHYA1 
        The expression of BmHYA1 was conducted using E.coli expression system, 
taking its advantage of being able to provide adequate amount of recombinant 
proteins. Both GST and His tag purification methods were employed. The sense 
primers for GST and His tag purification were GCC GGA TCC ACA TCT GCC GAC 
TTT AAG GTG and GAT CAT ATG CAT CAC CAT CAC CAT CAC ACA TCT GCC 
GAC, containing BamH I and Nde I restriction sites, respectively. The antisense 
primer was ATT GTC AAA TTG CAC CTT GAC TCG AGC GCG for both GST and 
His tag expressions, containing Xho I restriction site. The sequence ACA TCT GCC in 
sense primers were artificially coded based on the Edman degradation results, for the 
first 3 N-terminal amino acid residues: T-S-A. Since in the cloning work, 20 clones 
(named F1 to F20) were screened and 10 were identified to contain the BmHYA1 3’ 
fragment insert. A positive Clone F18 was randomly selected among those clones 
which contain the standard BmHYA1 cDNA 3’ end sequence (for “standard 
sequence”, see section 3.12.4), as the PCR template. The PCR products, i.e., the 
cDNA fragments of interest were subcloned at BamH I and Xho I, or Nde I and Xho I, 
sites of the pET41a(+) vector (Novagen, San Diego, CA, USA) and amplified with 
DH5α competent cells. The insert was confirmed in the correct reading frame by DNA 
sequencing. BL21 competent cells (Novagen, San Diego, CA, USA) were 
transformed by chimeric plasmids with GST or His tags. The transformants were 
cultured on the LB plate (with 50 µg/mL kanamycin). A single clone was selected to 
culture in 5 mL LB medium (with 50 µg/mL kanamycin), shaking at 220 rpm, 37 oC 
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overnight. Then 100 mL LB medium (with 50 µg/mL kanamycin) was inoculated with 
2 mL LB medium, which was taken out from the above 5 mL LB medium. The 
bacteria were incubated at 37 oC with agitation until its OD value achieving 0.4-0.8 
(about 2 hours). IPTG was then added to the cultural medium to reach a final 
concentration of 0.4 mM. The medium was collected after 4 hours of IPTG addition. 
Before IPTG was added, 3 mL of the cultural medium was collected as the expression 
control. The expression of recombinant protein collected, concentrated and purified 
by GST purification or His purification methods, according to the product manuals 
respectively (GST: GST purification modules, GE healthcare, Piscataway, NJ, USA; 
His: Protino, Macherey-Nagel, Düren, Germany). The existence of the expressed 
recombinant BmHYA1 was examined by SDS-PAGE. The activity of recombinant 
BmHYA1 was tested by the method described in section 2.3. 
 
2.7 Biological activity 
        2.7.1 Cell culture 
        The human breast cancer cell line MDA-MB-231 was a gift from Dr. Bay B.H., 
Dept. of Anatomy, National University of Singapore. This cell line is selected due to 
its availability and its aggressive property. In pilot study, MCF-7, a non-invasive 
breast cancer cell line and MDA-MB-231, a highly metastatic breast cancer cell line 
(Tai et al., 2003) were stained and compared, MDA-MB-231 was confirmed to 
contain much more hyaluronan and chosen as the experimental subject. The cells were 
cultured in Dulbecco's Modified Eagle's Medium (DMEM, ATCC, Manassas, VA, 
 60
Chapter 2: Materials and Methods 
USA), supplemented with 10% fetal bovine serum (FBS, Gibco-Invitrogen, Carlsbad, 
CA, USA), at 37 oC, under 5% CO2 in a humid atmosphere. 
 
        2.7.2 Immunohistochemical staining for hyaluronan 
        MDA-MB-231 cells were sub-cultured in 96-well plate, in the presence and 
absence of BmHYA1 (approximately 100 units) for 20 hours. The cells were fixed 
with 4% paraformalclehyde for 30 minutes. After washing 3 times with PBS, the cells 
were pre-incubated with 6% normal goat serum (NGS) in PBS-T (PBS with 0.2% 
Tween) for 60 minutes at room temperature and washed with PBS for 3 times. The 
cells were then incubated with 200 µL of diluted biotinylated HA-binding peptide 
(bHABP, Sigma, St. Louis, MO, USA) at the final concentration of 1.25 µg/mL, 
overnight at 4 oC. Finally, the wells were washed for 3 times with PBS and incubated 
for 1 hour with avidin-labeled horseradish peroxidase solution (Pierce, Rockford, IL, 
USA). Quantitative analysis of 3,3'-diaminobenzidine (DAB) staining was done by 
measuring the OD values of the cells (using ImageJ software, U. S. National Institutes 
of Health, Bethesda, Maryland, USA) against the background. 
 
        2.7.3 Western blot analysis for investigating the effect of the enzyme on the 
expression of cancer-related biological molecules 
        CD44 was chosen as the study subject is because it is one of the main receptors 
of hyaluronan (Stern et al., 2001). CD44 has various isoforms (Naor et al., 1997); in 
pilot study, CD44 standard isoform and variant isoforms 7 and 6 (CD44v6) were 
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tested for the possible expression changes by treatment of hyaluronidase and the first 
two isoforms were not detected to have obvious fluctuation, hence CD44v6 was 
selected for the further study. In the test, cells were incubated in the medium in the 
presence and absence of BmHYA1 (approximately 100 units), for 12, 24 and 48 hours. 
Cells were lysed with cell lysis buffer (Pierce, Rockford, IL, USA) and centrifuged at 
12,000 ×g to remove the insoluble platelets. Protein concentrations were determined 
using Bio-Rad protein assay kit (Hercules, CA, USA). The calibrated protein samples 
were loaded onto 8% sodium dodecyl sulfate-polyacrylamide gel for electrophoresis 
and then transferred to nitrocellulose membranes. The membranes were blocked in 
PBS-T (PBS with 0.2% Tween-20) solution with 5% skim milk for 1 hour. After that 
the membranes were incubated with 1:200 dilution of anti-CD44v6 monoclonal 
antibody (Santa Cruz, Santa Cruz, CA, USA) or 1:5000 anti-β actin mAb (Santa Cruz, 
Santa Cruz, CA, USA) in PBS-T overnight at 4 oC. The membranes were washed with 
PBS-T for 15 minutes three times and then incubated for 45 minutes with horseradish 
peroxidase-conjugated anti-mouse IgG Ab (Bio-Rad, Hercules, CA, USA) for 
CD44v6 and β-actin mAbs. The secondary antibody was detected by 
chemiluminescence system (Amersham, Piscataway, NJ, USA). 
 
2.8 Statistical analysis  
        The quantitative data were obtained in triplicate experiments and were expressed 
as mean ± S.E.M. The difference between any two groups was examined by student’s 













Chapter 3: Results and Observations 
3.1 The crude venom 
After dissolution, centrifugation and filtration, measurement of protein 
concentration of the crude venom solution by Bio-Rad protein assay indicated that 
protein accounted for 36% of the total weight of the crude venom.  
 
3.2 Preliminary separation of BCV and biological activity screening 
 
    3.2.1 Preliminary separation of BCV 
    In the first step, BCV was separated by gel filtration on Superdex G75 column. A 
total of 10 peaks eluted from the column were collected and pooled to represent 
different fractions: peak 1 (42~52 mL), peak 2 (56~62 mL), peak 3 (64~67 mL), peak 
4 (73~79 mL), peak 5 (81~97 mL), peak 6 (98~105 mL), peak 7 (106~113 mL), peak 
8 (114~117 mL), peak 9 (118~133 mL) and peak 10 (134~141 mL). The numbers in 
parentheses showed the elution volumes (as indicated by horizontal bars in 
Fig.3.1.(A). The components of 10 peaks were pooled and subjected to 15% SDS-
PAGE to analyze the M.W. distributions. The M.W. distribution pattern of SDS-PAGE 
was found to be consistent with the chromatographic behavior of the eluted fractions, 
indicating gradual distribution of proteins from high to low M.W. species (Fig. 3.1.B). 
To further investigate the detailed distribution pattern of high M.W. components, 
aliquots of eluants from every alternate tubes were subjected to 15% SDS-PAGE. 
SDS-PAGE analysis (Fig. 3.2) confirmed that in BCV, there was a preponderance of 
high M.W. proteins having M.W. greater than 14 kDa, with the highest found to be 
 63
 
Chapter 3: Results and Observations 
around 200 kDa, while the majority of proteins had M.W.s between 14 and 75 kDa. 
The high M.W proteins were mainly eluted in peaks 1 ~ 4, after which the eluates in 
later fractions contained mainly small peptides with M.W.s below 10 kDa. Since 
common SDS-PAGE cannot separate very low M.W. peptides, MS was used instead 
to investigate the M.W. distributions of the collected eluates from peaks 5 to 10. 
Based on the MS results, the low M. W. peptides can basically be classified into two 
groups, one with a M.W. around 3 kDa and the other around 7 kDa. These results are 
in agreement with those reported previously for BmK scorpion venoms (see review 
Goudet et al., 2002). When checked for the M. W. distribution pattern of the eluted 
proteins in individual peaks, it was found that the peptides in peaks 5 and 7 had 
M.W.s around 3 kDa, while peak 6 contained peptides with M.W. evenly distributed 
between 5~8 kDa. Peak 8 consisted of about 7 kDa peptides, whereas peak 9 
contained both of the two groups, and lastly peak 10 had the composition similar to 
peak 9. The protein concentration of the pooled elution peaks were then measured 
preparing for screening of biological activities. 



























Fig.3.1. Gel filtration chromatography (A), and SDS-PAGE pattern of the gel 
filtration factions (B).  
(A): Crude venom was separated by gel filtration on Superdex G75 column. The 
elution buffer was 50mM NH4HCO3, pH 8.9. The fractions representing 10 peaks 
were pooled as indicated by the horizontal bars. (B): 15% SDS-PAGE profile for BCV 
and 10 pooled peaks. Lanes from left to right: PS (Protein standards), BCV, peaks 1 to 
10, PS. The protein standards in lanes 1 and 13 (shown in duplicate) indicated the 
M.W. (kDa) of (a)250, (b)150, (c)100, (d)75, (e)50, (f)37, (g)25, (h)20, (i)15, and 
(j)10, respectively.  
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Fig. 3.2. SDS-PAGE profile of gel filtration fractions eluted from peak 1 to 4. Eluates 
from alternate tubes covering elution volumes from 41 to 87 mL were examined. (A) 
From left to right, PS (protein standards), tubes 41~67 (mL). (B) From left to right, 
PS, tubes 69~87 (mL). Protein standards (kDa): (a)250, (b)150, (c)100, (d)75, (e)50, 
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    3.2.2 L-amino acid oxidase (LAAO)activity:   
    LAAO enzyme activity was identified in BCV. The activity was much weaker 
compared to that of snake Naja Kaouthia crude venom (Fig. 3.9), which was included 
as a positive control in the experiment.  
 
    3.2.3 Fibrinogenolytic activity 
The activity was mainly associated with the first 3 peaks based on SDS-PAGE 
analysis (Fig.3.10). The Aα-chain of fibrinogen was apparently degraded in the first 
three peaks (indicated by a red circle), while the Bβ- and γ chains were barely affected. 
Further experiment was conducted to narrow down the active fractions. Every 
alternate tubes collected after chromatography (i.e., elution volume from 47 to 81 mL) 
were monitored for the activity. The absence of bands in the SDS-PAGE of the 
fraction corresponding to tubes #55 to 57 indicated that Aα chains were degraded, 
whereas the other tested fractions remained intact indicating that no degradation was 
apparent. The venom was thus confirmed to have Aα fibrinogenolytic activity.  
 
    3.2.4 Hemolytic activity 
The effect on both the whole blood (Fig. 3.11) and the red blood cell (RBC) 
(Fig.3.12) were tested. The hemolytic activity was found in all the fractions but not in 
crude venom. The highest effect was found in Peak 7. The negative control was the 
NH4CO3 buffer, and the positive control was Triton X-100. The activity of all the 10 
fractions showed relatively weak effect on both whole blood and RBC as compared to  
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Fig.3.9. LAAO activity test. It showed that BCV contained LAAO activity, but the 
activity of BCV was much weaker than that of snake Naja Kaouthia crude venom. 
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(C) 











Fig.3.10. Fibrinogen degradation in the gel filtration factions.  
(A), pooled fractions representing the 10 peaks. Lanes from left to right: PS (protein 
standards), followed by fibrinogen bands P1~P10, representing peaks 1~10. Note that 
the fibrinogen Aα chains were degraded (bands absent) in P1, P2 and P3 (marked by 
red circle); (B~C), alternate fractions collected throughout the chromatographic step.  
(B), Lanes from left to right: PS (protein standards), followed by fibrinogen bands 
from the alternate fractions (tubes #41~67). Note that fibrinogen Aα chains were 
degraded in lanes 9~10 (tubes #55 and #57). (C), Lanes from left to right: fibrinogen 
bands from alternate fractions (tubes #69~81), and PS (last lane). The results 
confirmed that the venom exhibited Aα fibrinogenolytic activity. 
For protein standards (kDa): (A) directly shown in figure; (B) and (C): (a)250, (b)150, 























Fig. 3.11. Whole blood hemolytic tests for BCV and all fractions. All the 10 fractions 
showed hemolytic activity on rat whole blood, whereas BCV did not. Asterisks 
indicated the significant difference between individual treatment group and control 


























Fig. 3.12. Red blood cell tests for the BCV and all the 10 fractions. All the fractions, 
but not the crude venom, showed hemolytic activity on RBC. Asterisks indicated the 
significant difference between individual treatment group and control group, 









Chapter 3: Results and Observations 
the positive control.  
 
    3.2.5 Antibacterial activity 
Neither the BCV (used at 1000 µg) nor all of its fractions showed any antibacterial 
activity. The crude venom from Naja Kaouthia snake used as a positive control 
showed obvious antibacterial activity at 100 µg. A round bacteria growth inhibition 
zone was observed where N. Kaouthia venom was applied (Fig.3.13, indicated by an 
arrow), while no other bacteria growth inhibition zone was found on the agar. 
 
    3.2.6 Amidolytic activity 
    Amidolytic activity was detected in BmK venom. As shown in Fig 3.14, the eluate 
fraction (i.e., 50~65 mL of elution volume) was observed to directly hydrolyze S-
2238. The activity region covered almost all the high M.W. protein fractions.  
 
    3.2.7 PLA2 activity 
    PLA2 activity was detected in the high M.W. eluates. Two activity peaks were 
located in peak 1, and also in between peaks 2 and 3 (Fig. 3.15). This indicated that 
BmK venom may have at least two high M.W. PLA2 isoforms.  
 
    3.2.8 Hyaluronidase activity 
The hyaluronidase activity was concentrated in peak 2. The activity of 
hyaluronidase at each chromatographic step was described in detail in the following 
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section.  
 
    The results of the screening were summarized in Table 3.1. 
 80
 















Fig.3.13. Test for anti-bacterial activity. The sketch map indicates the loading 
positions (approximately at blue and red small circles) of the samples. Naja 
Kaouthia crude venom (positive control, indicated by arrow in left figure) showed 
strong anti-bacterial activity. For BmK, neither crude venom nor its fractions showed 






























Fig. 3.14. Amidolytic activity identification with Gel filtration superdex G75 
chromatography. The fractions with amidolytic activity on S-2238 were indicated by 


























Fig. 3.15. PLA2 activity identification with Gel filtration superdex G75 
chromatography. The fractions with PLA2 activity were indicated by the dash-dotted 
line. It showed two activity peaks in 1), peak 1 (around fraction #49) and 2), in 














        
 




Table 3.1. The results of screening of BmK venom activity.  
Activities Crude venom Peak1 Peak2 Peak3 Peak4 Peak5 Peak6 Peak7 Peak8 Peak9 Peak10
LAAO        + N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D.
Fibrinogenolytic N.D.           + + + - - - - - - -
RBC            - + + + + + + + + + +Hemo- 
Lysis Whole -           + + + + + + + + + +
Anti-bacterial            - - - - - - - - - - -
Amidolytic            N.D. + + + - N.D. N.D. N.D. N.D. N.D. N.D.
PLA2 N.D.           + +/- +/- - N.D. N.D. N.D. N.D. N.D. N.D.
Hyaluronidase            + - + - - N.D. N.D. N.D. N.D. N.D. N.D.
               (+), activity present; (-), activity absent; (N.D), not determined. 
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3.3. Purification of BmK venom hyaluronidase BmHYA1 
 
    3.3.1 Gel filtration chromatography 
    A total of 10 fractions were separated by Superdex G75 gel filtration chromatography 
from BCV. The high molecular weight fractions were eluted mainly in the first 4 peaks, 
with the highest hyaluronidase activity found in peak 2 (Fig. 3.16). Peak 2 was collected 
(indicated by the horizontal bar) for further separation. 
 
    3.3.2 Anion exchange chromatography 
    Peak 2 was subsequently applied to anion exchange chromatography using UNOQ1 
column, equilibrated with 50 mM NH4HCO3 solution, pH 8.9. The column was eluted 
with a linear gradient of 1 M NaCl. Peak 2 was resolved into six peaks, with peak 1 
(unbound part) showing hyaluronidase activity (Fig. 3.17). The unbound component was 
collected (indicated by the horizontal bar) and lyophilized for further separation. 
 
    3.3.3 Cation exchange chromatography 
    The lyophilized components were re-dissolved in sodium acetate buffer (50 mM, pH 
5.0) and subjected to cation exchange chromatography on UNOS1 column. A linear NaCl 
gradient elution resolved the components further into 3 peaks, with the peak 3 found to be 
positive for hyaluronidase activity (Fig. 3.18).  
 
    3.3.4 RP-HPLC 
    Finally, peak 3 (indicated by a horizontal bar in Fig 3.18) was applied on a Sephasil C8 
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RP-HPLC column and a single peak with hyaluronidase activity was collected after 
elution with 0.1% TFA in 80% acetonitrile (Fig. 3.19). A summary of the purification 
process is shown in Table 3.2. From 200 mg of crude venom, 0.32 mg of purified 
hyaluronidase was obtained, with a yield of 12.4%. Specific activity increased by 77.5-
fold after purification.  
 
 
Table 3.2. Summary of purification process 












Crude venom              200 244 48,800 1.0 100 
Superdex G75 21.6 1,366 29,505 5.6 60.5 
UNOS1 0.91 9,010 8,199 36.9 16.8 
RP-HPLC C8 0.32 18,900 6,048 77.5 12.4 
 
 
3.4. Homogeneity and molecular weight of BmHYA1  
    The homogeneity of BmHYA1 was indicated by a single band of SDS-PAGE, as 
shown in Fig.3.20. Based on the M.W. of protein standards, the M.W. of BmHYA1 was 
estimated to be 48 kDa. MALDI-TOF MS showed a symmetric peak (Fig. 3.21), 
indicating a M.W. of 48,696 Da. The results of SDS-PAGE and MALDI-TOF MS were 
found to be consistent. In addition, no other peptide contaminants other than the target 





















Fig. 3.16. Superdex G75 gel filtration chromatogram. The elution buffer was 50 mM 
NH4HCO3, pH 8.9. Out of the 10 peaks eluted from the column, peak 2 was associated 
with hyaluronidase activity and was collected for further separation (indicated by a 
































Fig.3.17. UNO Q1 anion exchange chromatogram. The column was pre-equilibrated with 
50 mM NH4HCO3, pH 8.9 buffer. The pooled fractions associated with peak 2 (collected 
from above gel filtration) were loaded and eluted with a linear gradient of 1 M NaCl. The 
unbound fraction containing hyaluronidase activity (indicated by a horizontal bar) was 































Fig.3.18. UNO S1 cation exchange chromatogram. The unbound fraction from UNO Q1 
column was lyophilized and re-dissolved in sodium acetate (50 mM, pH 5.0), and 
fractionated on the cation exchange column UNOS1. The column was pre-equilibrated 
with 50 mM sodium acetate buffer, pH 5.0, and the elution was achieved with a linear 
gradient of 1 M NaCl. The last peak containing hyaluronidase activity (indicated by a 



























Fig.3.19. RP-HPLC chromatogram of BmHYA1. The pooled fraction obtained from 
UNO S1 cation exchange chromatographic step was purified on RP-HPLC Sephasil C8 
column equilibrated with buffer A (0.1% TFA). Elution was done by applying a linear 
gradient of buffer B (0.1% TFA in 80% acetonitrile). The protein was eluted at a very 































Fig. 3.20.  SDS-PAGE of BmHYA1. Left Panel: Lane 1, p
venom of BmK; lane 3, gel filtration peak 2; lane 4, B







 Purified BmHYA1rotein standards; lane 2, crude  
mHYA1. Left panel showed the 
y 48 kDa. Right panel: purified 
91
 

















Fig.3.21. MALDI-TOF MS showed the M.W. of BmHYA1 to be 48696 Da, which was 
consistent with the M.W. estimated from SDS-PAGE profile. The single symmetric peak 
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3.5 N-terminal sequence of BmHYA1 
    Thirty N-terminal amino acids of BmHYA1 were determined by Edman degradation to 
be: TSADF-KVVWE-VPSIM-CSKKF-KICVT-DLLTS. The N-terminal amino acid 
sequence of BmHYA1, and the hyaluronidases from honeybee and stonefish (SFHYA1) 
venom were then compared. The N-terminal sequence of BmHYA1 shared about 30% 
identity to honeybee venom hyaluronidase and 16% to SFHYA1 (Fig. 3.22 (A)).  It is of 
interest to note that the two cysteine positions in the BmHYA1 N-terminal sequence were 
located exactly as the ones in the N-terminal sequence of the scorpion Tityus stigmurus 
hyaluronidase (Fig. 3.22 (B)). 
 
3.6 Optimal pH profile 
    The acidic environment was essential for BmHYA1 enzyme activity. As demonstrated 
in Fig.3.23, the optimal pH of BmHYA1 was 4.5. The enzyme showed little activity at pH 
values below 2 or above 10.  
 
3.7 Optimal temperature profile 
    The optimal temperature of BmHYA1 was 50 oC, as demonstrated in Fig. 3.24. Since 
most of the venom hyaluronidases show their optimal temperature around 37 oC 
(Kemparaju and Girish, 2006; Pessini et al., 2001; Girish et al., 2002; Morey et al., 2006), 
a venom and a mammalian tissue hyaluronidase with known optimal temperature were 
used for comparison with that of BmHYA1. It was noted that while the activity of the D.  
russelii venom hyaluronidase declined considerably at 50 oC, the optimal temperature for  
 





Hyaluronidases  Thirty N-terminal amino acids  Ref. 
BmHYA1 ---------TSADFKVVWEVPSIMCSKKFKICVTDLLTS Present study 
Honeybee Hyaluronidase ------NNKTVREFNVYWNVPTFMC-HKYGLRFEEVS-- Gmachl and Kreil, 1993 
SFHYA1 LPWTDPPLHPGHPFLFTWNAPTELC----GIRFG----- Ng et al., 2005 
 
Fig. 3.22. (A) 
Comparison of thirty N-terminal amino acids of three venom hyaluronidases. The symbol letters in frame indicated the same positions 
of the three hyaluronidases. The table showed BmHYA1 shared up to approximately 30% of identity to other venom hyaluronidases 






Fig. 3.22. (B) 
Comparison of N-terminal sequences of BmHYA1 and T.stigmurus scorpion venom hyaluronidase. Two cysteine positions at the 16th 
and 23rd amino acids of BmHYA1 were found to be identical with those of the hyaluronidase from Tityus stigmurus scorpion venom. 
The lysines also appeared at the same position (the 19th amino acid). 




20 25 30 Ref. 
1.BmK (scorpion) TSADF KVVWE VPSIM CSKKF KICVT DLLTS Present study 
2.Tityus stigmurus (scorpion) EHPAL YRRYS KEHTF CKTKN QXCN  Batista et al., 2007 
 
 


















Fig. 3.23.  Optimal pH profile of BmHYA1. Different buffer systems were used to 
provide varying pH settings. Maximal activity was set at 100% and the baseline activity 


























Fig.3.24. Optimal temperature profile of BmHYA1. The optimal temperature profile of 
BmHYA1 was compared with hyaluronidases from bovine testis and D.russelii venom. 
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both BmHYA1 and bovine testicular hyaluronidase remained same at 50 oC. 
 
3.8 Thermostability 
    BmHYA1 was pre-incubated in various temperatures for 10 minutes before its activity 
was tested. Its activity was found to be unstable to the temperature change. As shown in 
Fig. 3.25, the activity declined slightly before reaching 24 °C, but began losing its 
activity rapidly from 24 °C onwards. At 65 °C, the enzyme was totally inactivated.  
 
3.9 Km and Vmax determinations 
    As demonstrated in Fig.3.26, Km and Vmax were determined as 95.3 µg/mL and 3.9 
µg/min, respectively. See section 2.5.6 for further details about Km and Vmax. 
 
3.10 Inhibition assays 
    Among the chemicals examined, heparin, DTT, Cu2+, and Fe 3+ showed inhibitory 
effect on BmHYA1, with the strongest effect found for heparin, which can reduce about 
80% of the activity. Reduced glutathione, L-Cysteine, EDTA, Mg2+ and Ca2+ failed to 
demonstrate any detectable inhibitory effect on BmHYA1 enzyme activity (Table 3.3). 
 
3.11 Deglycosylation assays 
    Assessing the degree of deglycosylation of BmHYA1 was by the mobility shifts on 
SDS-PAGE. As shown in Fig. 3.27, the extent of deglycosylation for BmHYA1 was 
observed by sequential addition of each of the three enzymes PNGase F, α-2(3,6,8.9)-
Neuraminidase, and O-Glycosidase. The noticeable shift of BmHYA1 bands between  
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Table 3.3. The inhibitory effect of different chemicals on BmHYA1.* 
Compounds % Inhibition 
  Ions  
    MgCl2 N.D. 
    CaCl2 N.D. 
    CuCl2 9.9±1.43 
    FeCl3 41.3±5.20 
  Others  
    Glutathione (Reduced)                         N.D. 
    L-Cysteine N.D. 
    EDTA     N.D. 
    DTT   7±2.26 
    Heparin 81.6±6.05 
 
* All chemicals were used at a fixed concentration of 5 mM, except heparin which was 


























Fig. 3.27. Deglycosylation analysis under reducing conditions by 15% SDS-PAGE. Lane 
1: protein standards (kDa): (a)250, (b)150, (c)100, (d)75, (e)50, (f)37, (g)25, (h)20, (i)15 
and (j)10; lane 2: BmHYA1 only; lane 3: BmHYA1+ PNGase F; lane 4: BmHYA1 + 
PNGase F + O-Glycosidase; lane 5: BmHYA1+ PNGase F + O-Glycosidase + α-
2(3,6,8,9) neuraminidase. A shift of two BmHYA1 bands between lane 2 and any of lane 
3, 4 or 5, was evident after PNGase treatment. No obvious shift of BmHYA1 bands was 
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lane 2 and any of land 3, 4 or 5 was observed, suggesting the removal of N-linked 
oligosaccharides by PNGase F. Among lanes 3, 4 and 5, no obvious shift was seen, 
indicating that BmHYA1 contains no or very small amount of O-linked oligosaccharides. 
 
3.12 End products of hydrolysis of hyaluronan by BmHYA1  
    The hyaluronidase enzymes hydrolyze the glycosidic bond of hyaluronan and 
subsequently generate oligosaccharides. In this study, the degradation product of 
hyaluronan by bovine testicular hyaluronidase, which is known as tetrasaccharide, was 
used as the marker of molecular size (Fig. 3.28 lane 1) to compare with that degraded by 
BmHYA1. Hyaluronan was incubated with BmHYA1 for 24 hours to obtain the 
completely digested substrate. Incubation of the hyaluronan and BmHYA1 for 24 hours 
showed the same pattern as the degradation product by bovine testicular hyaluronidase 
(Fig. 3.28 lane 2). The results suggested that tetrasaccharide was the main product when 
hyaluronan was completely degraded by BmHYA1. 
 
3.13 The molecular biological study 
 
    3.13.1 RNA isolation and integrity test 
    Total RNA was isolated from the pair of venom glands of a single BmK scorpion. 
Totally 28 µL of 82 ng/µL total RNA (approximately 2.3 µg) was yielded. The integrity 
was tested by native agarose gel (1.5%). The electrophoresis of total RNA in agarose gel 
showed that the 28S and 18S bands were clear, with 18S band appeared to be brighter and 
broader than the 28S band. Neither the smaller band nor any smeared area was detected  
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Fig.3.28. Thin layer chromatogram of degradation products of hyaluronan by BmHYA1. 
Hyaluronan was incubated with Bovine testicular hyaluronidase and with BmHYA1 for 
24 hours separately. From the chromatogram, the degradation products of hyaluronan by 
BmHYA1 (lane 2) showed a similar chromatographic pattern to the degradation products 
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below the 18S band. The integrity of the RNA sample was thus confirmed for further 
processing. 
 
    3.13.2 RT-PCR and 3’ RACE  
    Using AP, ss cDNA was synthesized from total RNA. RNA template was degraded by 
RNase H. The 3’ RACE PCR was primed with BmHYA1-GSP and AUAP. The 3’ RACE 
product of rat GAPDH primer and AUAP was found to contain a smeared area spanning 
500 to 2000 bp region (Fig. 3.29, lane 2), thus non-specific binding might have probably 
occurred. It appeared likely that the nucleotide sequences between rat and BmK scorpion 
GAPDHs was different. The 3’ end of BmK AS-1 from the primer was about 300 bp, and 
based on the length of this cDNA, the band of approximately 300 bp detected in lane 3 
indicated that it was most probably the 3’ end of BmK AS-1. It also confirmed the good 
quality of this cDNA material. Lane 4 also showed a smeared area, which might be due to 
the unspecific binding of SFHYA1-GSP to BmHYA1 sequence. A band of approximately 
1.3 kb and a smeared area underneath were detected in lane 5. A degenerate primer 
containing a mixture of various primers commonly generates a heterogeneous product. 
Judging by the molecular size (48 kDa) of BmHYA1, this 1.3 kb band might probably 
represent the BmHYA1 3’ end of cDNA. Hence, it was excised and purified from the gel 
for further study. 
 
    3.13.3  TA cloning of the 1.3 kb fragment  
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Fig. 3.29. Electrophoresis for 3’ RACE PCR product. Lane1: 500 bp ladder; lane2: rat 
GAPDH primer and AUAP PCR product; lane3: BmK AS-1 primer and AUAP PCR 
product; lane 4: hyaluronidase universal primer and AUAP PCR product; lane 5, 
BmHYA1-GSP and AUAP PCR product. All of the four PCR reactions were conducted at 
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product was transformed into E.coli strain DH5α competent cells. After incubation at 37 
oC overnight, 20 positive (white) clones were picked. Out of the selected clones, 10 were 
found to be successfully inserted with the target fragments (for methods see section 
2.6.4.5) and were applied for sequencing. The representative result for the first 5 selected 
clones was shown in Fig 3.30. Clones F2 and F3 were tested to contain the sequences 
belonging to Glycol-Hydro-56 family. 
 
    3.13.4 3’ end cDNA nucleotide and full length protein sequences of BmHYA1 
    Nucleotide sequence and deduced amino acid sequence of BmHAY1 were listed in 
Fig.3.31. The 3’ end of cDNA of BmHYA1 gene was cloned. The translational 
termination codon of this cDNA was assigned to the TGA codon (marked as asterisk in 
Fig. 3.31). The downstream of this TGA codon, a putative polyadenylation signal of 
AATAAA was observed (underlined by a wavy line in Fig. 3.31). The DNA sequence 
containing stop codon and poly A tail indicates the completion of 3’ UTR. Since 
BmHYA1-GSP was designed based on the known N-terminal protein sequence, the 
deduced protein sequence along with the Edman degradation result provided the whole 
amino acid sequence of mature BmHAY1 protein. BmHYA1 mature protein contains 385 
amino acids including 12 cysteines. Among 10 successful clones, the sequences have 
some discrepancies: clone F15, T for A at position 77; clone F2, G for W at position 107, 
F for L at position 110; clone F10, G for W at position 210. The predominant sequence 
was picked as the standard. Between experimental and theoretical sequences, only one 
mismatched position was found. Cysteine at position 23rd of N-terminal amino acid 
sequence was found out to be asparagine as deduced from the nucleotide codon.  
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    Since BmHYA1 is the first scorpion venom hyaluronidase ever characterized at the 
molecular level, it is significant to investigate its structure relationship to other known 
hyaluronidases.  
       
      BmHYA1 was aligned with other hyaluronidases using Cluster W algorithm 
(Thompson et al., 1994, Fig.3.32). In addition, a phylogenetic tree was generated to 
further investigate the relationship of BmHYA1 to its 26 homologues (all belong to 
glycol-hydro-56 superfamily), including the hyaluronidases of C.elegans and 
representative of mammals, snakes, insects and fish (Fig. 3.33). Among these 
homologues, the sequence identity of BmHYA1 to any of the other hyaluronidases did 
not exceed 34%. The closest BmHYA1 homologues are hyaluronidases of white-face 
hornet and yellow jacket wasp (both 34% identity) In the tree, C. elegans formed a 
cluster separated from all other hyaluronidases. Similarly, BmHYA1 was also located 
distantly to other hyaluronidases and formed a separate cluster. The phylogenetic analysis 



























Fig. 3.30. The 
were examined










 1000bpp 500bverification of inserts. The PCR products (using T7 and SP6 as primers) 
 by agarose gel electrophoresis. From left to right: DNA ladder (500 bp), 
 F5. F2~F5 showed the expected sizes (around 1.3 kb) and then were sent 
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                                          T  S  A 
GACTTTAAGGTGGTTTGGGAGGTTCCTTCGATAATGTGTAGCAAAAAGTTT 
D  F  K  V  V  W  E  V  P  S  I  M  C  S  K  K  F   
AAAATTAATGTTACAGATTTGCTTACAAGCCACAAAATATTGGTCAATCAA 
K  I  N  V  T  D  L  L  T  S  H  K  I  L  V  N  Q   
GAAGAGACGTTTAACGGAGATAAAATTGTAATCTTCTATGAGAGCCAACTC 
E  E  T  F  N  G  D  K  I  V  I  F  Y  E  S  Q  L   
GGAAAATATCCTCATATAGAATCTCATGGAGATATCAATGGAGGGATGTTG 
G  K  Y  P  H  I  E  S  H  G  D  I  N  G  G  M  L   
CAAGTTTCAGATTTAGCGAATCATTTAAAGATTGCGAGAGATAACATATCG 
Q  V  S  D  L  A  N  H  L  K  I  A  R  D  N  I  S   
AAATTTATACCCGATCCAAATTTTAATGGAGTTGGAATTATAGACTGGGAA 
K  F  I  P  D  P  N  F  N  G  V  G  I  I  D  W  E   
GCATGGCGTCCTCTCTGGAAATACAATTGGGGTAGGATGAGTGAGTACAGG 
A  W  R  P  L  W  K  Y  N  W  G  R  M  S  E  Y  R   
GATAGATCAAAAGATCTTGTAAAAGCTAAACATCCAGATTGGTCACCGGCT 
D  R  S  K  D  L  V  K  A  K  H  P  D  W  S  P  A   
CAAATCGAAAAAGTTGCTATAGAGGAATGGGAAAACAGTGCCAAAGAGTGG 
Q  I  E  K  V  A  I  E  E  W  E  N  S  A  K  E  W   
ATGCTTAAAACACTGAAGCTTGCAGAAGATATGAGGCCTAATGCAGCATGG 
M  L  K  T  L  K  L  A  E  D  M  R  P  N  A  A  W   
TGTTACTATCTGTTTCCCGACTGTTATAACTATGGTGGGAAAGATCAACCT 
C  Y  Y  L  F  P  D  C  Y  N  Y  G  G  K  D  Q  P   
TCAGAATATTTTTGCAAGAATGATATACAAGAAGCAAACGACAAATTATCC 
S  E  Y  F  C  K  N  D  I  Q  E  A  N  D  K  L  S   
TGGTTGTGGAAACAAAGTACAGCTCTTTGCCCTTCGATATACATGCAAGAA 
W  L  W  K  Q  S  T  A  L  C  P  S  I  Y  M  Q  E   
TCGCACATAACGAAATATAACACATCTCAACGCGCATGGTGGATATATGCT 
S  H  I  T  K  Y  N  T  S  Q  R  A  W  W  I  Y  A  
CGTCTAAGGGAAACCATAAGATTATCACATCCTAATACTCTCATTTATCCA 
R  L  R  E  T  I  R  L  S  H  P  N  T  L  I  Y  P  
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TATATAAACTACATTTTGCCAGGAACTAAGAAGACGGTACCATCGATGGAT 
Y  I  N  Y  I  L  P  G  T  K  K  T  V  P  S  M  D  
TTTAAAAGAGTATTAGGACAGATAGGATCTCTGGGTCTGGACGGTGCTATC 
F  K  R  V  L  G  Q  I  G  S  L  G  L  D  G  A  I  
ATTTGGGGATCTTCTTATCATGTGAATACCGAAGGAATGTGTAAAGAAATG 
I  W  G  S  S  Y  H  V  N  T  E  G  M  C  K  E  M  
AAAACCTACGTGAAAGATGTGATTGCTCCTGTAGCTAGTACTGTGATACAA 
K  T  Y  V  K  D  V  I  A  P  V  A  S  T  V  I  Q  
AATGTCAATCGATGTAGTCAGCAAATCTGCAAAGGAAGAGGAAATTGTGTA 
N  V  N  R  C  S  Q  Q  I  C  K  G  R  G  N  C  V  
TGGCCAGAAGAACCTTATACCTCATGGAAGTATCTGATCGATCCCAAAAAT 
W  P  E  E  P  Y  T  S  W  K  Y  L  I  D  P  K  N  
CCGACATTCAAACATACTAACATCTCTTGCAAATGCAAAGGTGGTTATACG 
P  T  F  K  H  T  N  I  S  C  K  C  K  G  G  Y  T  
GGACGTTATTGTCAAATTGCACCTTGAGATTTTCTACCTGATCGCAATACT 






Fig. 3.31. Full length deduced amino acid sequence of BmHYA1 and its molecular 
characterization. Amino acid residues including the first 3 N-terminal amino acid residues 
(T-S-A) obtained by Edman degradation are underlined. The boldfaced amino acid 
residues indicate the sequence used for designing the degenerate primer. The five 
potential glycosylated asparagines are shaded. The stop codon TGA is indicated by an 
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                                                                                *      #        
BmHYA1         -----------------------------------------------TS---ADFKVVWEVPSIMCSKKFKINVTDLLTS        30 
Honeybee HYA   --------MSRPLVITEGMMIG----VLLMLAPINALLLGFVQSTPDNNKTVRE.N.Y.N..TF..H-.YGLRFEEVSEK        67 
SFHYA1         --MIK---LKFLYVQHFFSIS-----VTMMSLLRSGGALPWTDPPLHPG---HP.LFT.NA.TEL.GIR.GMPLD--.SY        65 
Snake Eo HYA   --------MYHLWIKCLA--------AWIFLKRFNGVHVMHAKAPMYPN---EP.L.F.NA.TTQ.RLRY.VDLD--.KT        59 
HYAL1          --------MAGHLLP-----------ICALFLTLLDMAQGFRGPLLPN----RP.TT..NANTQW.LERHGVD.D--VSV        55 
HYAL2          --------MRAGPGPTVT--------LALVLAVSWAMELKPTAPPIF.G---RP.V.A.D..TQD.GPRL.VPLD--.NA        59 
HYAL3          --------MTTQLGP------------ALVLGVALCLGCGQPLPQVPE----RP.S.L.N...AH.EAR.GVHLP--.NA        54 
HYAL4          MKVLSEGQLKLCVVQPVHLTS----WLLIFFILKSISCLKPARLPIYQR---KP.IAA.NA.TDQ.LI.YNLRLN--.KM        71 
Human PH-20    MGVLK---FKHIFFRSFVKSSGVSQIVFTFLLIPCCLTLNFRAPPVIPN---VA.LWA.NA..EF.LG..DEPLD--MSL        72 
 
                                                                           #                ♦ ● 
BmHYA1         HKILVNQEETFNGDKIVIFYESQLGKYPHIES-----HGDINGGMLQVSDLANHLKIARDNISKFIPDPNFNGVGIIDWE       105 
Honeybee HYA   YG..Q.WMDK.R.EE.A.L.DP--.MF.ALLKDPNGNVVAR...VP.LGN.TK..QVF..HLINQ...KS.P...V..F.       145 
SFHYA1         FDFVSSTLKSATNQS.S...TDRF.VF.YVNEK---TGKMY...LP.LI..EQ.HEL.E.D.EYY..FNQLG-LAVL.F.       141 
Snake Eo HYA   FH.VA.AND.LS.SAVT...PTH..I....DD----RGHFFH.IIP.NES.TK..DKSKSD.NRI..LKT.H.L.V....       135 
HYAL1          FDVVA.PGQ..R.PDMT...S....T..YYTP----TGEPVF..LP.NAS.IA..ARTFQD.LAA..A.D.S.LAV....       131 
HYAL2          FDVQASPN.G.VNQN.T...RDR..L..RFD.----AGRSVH..VP.NVS.WA.R.MLQKRVEHY.RTQESA.LAV....       135 
HYAL3          LG.IA.RGQH.H.QNMT...KN...L..YFGP----RGTAH...IP.ALP.DR..AL.AYQ.HHSLR-.G.A.PAVL...       129 
HYAL4          FPVIGSPLAKAR.QNVT...VNR..Y..WYT.----QGVP....LP.NIS.QV..EK.DQD.NYY..AED.S.LAV....       147 
Human PH-20    FSFIGSPRINAT.QGVT...VDR..Y..Y.D.I---TGVTV...IP.KIS.QD..DK.KKD.TFYM.VD.LG-MAV....       148 
 
                                                                                   ◊ ♦    *     
BmHYA1         AWRPLWKYNWGRMSEYRDRSKDLVKAKHPDWSPAQIEKVAIEEWENSAKEWMLKTLKLAEDMRPNAAWCYYLFPDCYN--       183 
Honeybee HYA   S...IFRQ..ASLQP.KKL.VEV.RRE..F.DDQRV.QE.KRRF.KYGQLF.EE...A.KR...A.N.G..AY.Y...--       223 
SFHYA1         E...Q.IR...SKDI..QY.IET.LK.NSSL.KEEAAGQ.KMAF.RA..KYF.RSIRIGKRL...RL.G...Y.E...YE       221 
Snake Eo HYA   N...Q.DR...NKNV..N..IQFARDL..EL.ENK.RRL.KA.Y.KA..SF.RD..L...E...DGY.G...Y...Q.YD       215 
HYAL1          ....R.AF..DTKDI..Q..RA..Q.Q....PAP.V.A..QDQFQGA.RA..AG..Q.GRAL..RGL.GF.G......--       209 
HYAL2          D...V.VR..QDKDV..RL.RQ..ASR....P.DR.V.Q.QY.F.FA.QQF..E..RYVKAV..RHL.GF........HD       215 
HYAL3          E.C...AG....RRA.QAA.WAWAQQVF..LD.QEQLYK.YTGF.QA.RAL.ED..RV.QAL..HGL.GF.HY.A.G.-G       208 
HYAL4          Y...Q.AR..NSKDV..QK.RK.ISDMGKNV.ATD..YL.KVTF.E...AF.KE.I..GIKS..KGL.G...Y...H.YN       227 
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                          *                     ◊   ♦         #                                 
BmHYA1         YGGKDQPSEYFCKNDIQEANDKLSWLWKQSTALCPSIYMQESHITKYNTSQRAWWIYARLRETIRLSHPNTL-----IYP       258 
Honeybee HYA   --LTPNQPSAQ.EATTMQE...M...FESEDV.L..V.LRWNLT----SGE.VGLVGG.VK.AL.IARQM.TSRK-KVL.       296 
SFHYA1         .KKDMAGYTGE.PAIEKDR.NE.L...RE....F....LELLLR---D.Q.ARQYVRH.IQ.S..V.KLPNSAYSIP.HA       298 
Snake Eo HYA   .KT.GDQYTGK.PDIEMSR..Q.L...RE....F.NV.LEIILR---SSDNALKFVHH..K.SM.IASMAREDYALPVFV       292 
HYAL1          .DFLSPNYTGQ.PSG.RAQ..Q.G...G..R..Y.....PAVLE---G.GKSQMYVQH.VA.AF.VAVAAGD-PNLPVL.       285 
HYAL2          .VQNWESYTGR.PDVEVAR..Q.A...AE....F..V.LD.TLA---SSRHGRNFVSF.VQ.AL.VARTHHANHALPV.V       292 
HYAL3          WHSMASNYTGR.HAATLAR.TQ.H...AA.S..F....LPPRLP---PAHH-QAFVRH..E.AF.VALVGHR-HPLPVLA       283 
HYAL4          VYA--PNYSGS.PE.EVLR.NE.....NS.A..Y...GVWK.LG---DSENILRFSKF.VH.SM.I.TMTSHDYALPVFV       302 
Human PH-20    .KK--PGYNGS.F.VEIKR..D.....NE....Y....LNTQQ----SPVAATLYVRN.V..A..V.KIPDAKSPLPVFA       302 
 
                                                   ♦           *                !       ▼    ▼  
BmHYA1         YINYILPGTKKTVPS-MDFKRVLGQIGSLGLDGAIIWGSSYHVNTEGMCKEMKTYVKDVIAPVASTVIQNVNRCSQQICK       337 
Honeybee HYA   .YW.KYQDRRD.DL.RA.LEAT.RK.TD..A..F......DDI..KAK.LQFRE.LNNELG.AVKRIAL.N.ANDRLTVD       376 
SFHYA1         .VRPVYKDSTDNYM.EF.LVNTI.EAAA..AASVVC..DMSV.A..DS.FDARRHLEK.MN.YIMN.STATQL..KAL.Q       378 
Snake Eo HYA   .ARPFY-AYTFEPLTQE.LVTTV.ETAAM.AA.IVF...MQYAS.VDS.QKV.K.MNGPLGRYIIN.TTAAKI..HAL.R       371 
HYAL1          .VQIFY-D.TNHFLP-------------------------L-----ES.QAI.E.MDTTLG.FILN.TSGALL...AL.S       334 
HYAL2          FTRPTY-SRRL.GL.E..LISTI.ESAA..AA.V.L..DAGYTTSTET.QYL.D.LTRLLV.YVVN.SWATQY..RAQ.H       371 
HYAL3          .VRLTH-RRSGRFL.QD.LVQSI.VSAA..AA.VVL..DLSLSSS.EE.WHLHD.LV.TLG.YVIN.TRAAMA..H.R.H       362 
HYAL4          .TRLGYRDEPLFFL.KQ.LVSTI.ESAA..AA.IV...DMNLTASKAN.TKV.QF.SSDLGSYIAN.TRAAEV..LHL.R       382 
Human PH-20    .TRIVFTDQVLKFL.QDELVYTF.ETVA..AS.IV...TLSIMRSMKS.LLLDN.METILN.YIIN.TLAAKM...VL.Q       382 
 
                   ▼                                         #      #  ▼ ▼                ▼    
BmHYA1         GRGNCVWPEEPYTSWKYLIDPK------------------------NPTFKHTNISCKCKGGYTGRY--------CQIAP       385 
Honeybee HYA   VSVDQ.                                                                                 382 
SFHYA1         DQ.R..RKHW-DDDVFLHL..RRYRIEQQRGGG--PLTVTGDLSQDDVNWFDR.FD.M.YSEKPC.S--------ALTFN       447 
Snake Eo HYA   KN.R..RKHS-DSNAFLHLF.ESFRIMVHANATEKKVIVKGKLELE.LIYLRE.FM.Q.YQ.WQ.L.--------.EEYS       442 
HYAL1          .H.R..RRTS-HPKALL.LN.ASFS--IQLTPGGGPLSLRGALSLEDQAQMAVEFK.R.YP.WQAPW--------.-E--       400 
HYAL2          .H.R..RRNP-SA.TFLHLSTNSFRLVPGHAPGEPQLRPVGELSWADIDHLQ.HFR.Q.YL.WS.EQ--------.-QWD       441 
HYAL3          .H.R.ARRDPGQMEAFLHLW.D---------------GSLGDW--------KS-F..H.YW.WA.PT--------.-Q--       407 
HYAL4          NN.R.IRKMW-NAPSYLHLN.ASYHIEASEDG---EFTVKGKASDTDLAVMADTF..H.YQ..E.AD--------.REIK       450 
Human PH-20    EQ.V.IRKNW-NS.DYLHLN.DNFAIQLEKGG---KFTVRGKPTLEDLEQFSEKFY.S.YSTLSCKEKADVKDTDAVDVC       458 
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BmHYA1                                                                                                385 
Honeybee HYA                                                                                          382 
SFHYA1         VINKAVIN---KAPPACDG---------TARSDVHCDVNINF                                             477 
Snake Eo HYA   IKDIRKI                                                                                449 
HYAL1          ---R---------KSMW                                                                      405 
HYAL2          HRQAAGGA-----SEAWAG---------SHLTSLLALAALAFTWTL                                         473 
HYAL3          --EPRPGP-----KEAV                                                                      417 
HYAL4          TADGCSGVS--PSPGSLMT---------LCLLLLASYRSIQL                                             481 





Fig. 3.32. Comparison of hyaluronidase sequences by Clustal W algorithm (Thompson et al., 1994). The sequences include: BmHYA1 
(present work), Honeybee HYA (honeybee venom hyaluronidase, AAA27730.1), SFHYA1 (stonefish venom hyaluronidase, 
AAO74499.1), Snake Eo HYA (snake E. ocellatus venom hyaluronidase, ABI33937.1), HYAL1~4 (human hyaluronidases 1~4, 
CAG46731.1, NP_149348.2, NP_003540.2, NP_036401.2) and Human PH-20 (AAC60607.2). The proposed catalytic Glu H-donating 
residue is denoted by “●”; the residues positioning the carbonyl nucleophile/base are denoted by “♦”. The conserved cysteines which 
have the counterparts in Honeybee HYA, i.e., Cys16, Cys181, Cys195 and Cys306, are identified by “*”; other conserved cysteines (Cys331, 
Cys336, Cys342, Cys370, Cys372 and Cys381) are noted by “▼”. Cysteines which may not be conserved in BmHYA1 sequence (Cys174 and 
Cys217) are indicated by “◊”. Potential N-glycosylation sites (N23-V-T, N86-I-S, N231-T-S, N360-P-T, N367-I-S) are marked as “#” above 
the corresponding asparagine residues. The highly conserved potential hyaluronidase N-glycosylation sites are marked by “!” at 
























Fig. 3.33. Phylogenetic tree of BmHYA1 and other 26 hyaluronidases. The protein 
sequences were aligned by Clustal W algorithm (Thompson et al., 1994) and the 
phylogenetic tree was constructed by MegAlign (Lasergene, DNASTAR, Madison, WI). 
The sequences involved in phylogenetic analysis are: BmHYA1 (this work), C. elegans 
hyaluronidase (CAA88874.1), sand fly hyaluronidase (AAD32195.1), honeybee (Apis 
mellifera) venom hyaluronidase (AAA27730.1), paper wasp hyaluronidase 
(AAD52616.1), white-face hornet hyaluronidase (AAA68279.1), yellow jacket wasp 
hyaluronidase (AAB48073.1), solitary wasp A. samariensis (BAF93867.1), mouse serum 
hyaluronidase (AAC15949.1), human HYAL-1~4 (CAG46731.1, NP_149348.2, 
NP_003540.2, NP_036401.2),  snake C. cerastes venom hyaluronidase (ABI33940.1), 
snake E. ocellatus venom hyaluronidase (ABI33937.1), snake B.arietans venom 
hyaluronidase (ABI33945.1), rat hyaluronidase (AAD01980.1), mouse HYAL2 
(AAK28481.1), SFHYA1 (stone fish venom hyaluronidase, AY232496), xenopus kidney 
hyaluronidase (AAD28281.1), rat sperm surface antigen, 2B1 (CAA62016.1), red fox 
PH-20 (AAB86588.1), cynomolgus monkey M.fascicularis PH-20 (L13780), mouse PH-
20 (BAC55070.1), human PH-20 (AAC60607.2), rabbit PH-20 (AAA88913.1) and 
Guinea pig PH-20 (CAA39768.1). 
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    3.13.5 Expression of BmHYA1 in E.coli system 
    The E.coli expression system was employed taking the advantage of its ability to 
express abundant proteins. In this work, attempts were made to produce recombinant 
BmHYA1 in E.coli expression system using the vector pET41a(+). GST and His tag were 
applied to facilitate the purification process.   
 
        3.13.5.1 Cloning of BmHYA1 cDNA in pET41a(+) vector 
        pET41a(+) vector combines a strong T7 promoter, which can be recognized by 
E.coli T7 RNA polymerase, and a lac operator repression module allowing the tight 
regulation of the expression process. The vector also contains multiple cloning sites to 
facilitate the varying insertion of interest protein genes. The cDNA of BmHYA1 was 
amplified and structured with restriction sites of BamH I and Xho I, or, Nde I and Xho I, 
respectively. After double digestion, the BmHYA1 gene was subcloned between BamH I 
and Xho I, or Nde I and Xho I sites in pET41a(+) vector. After an overnight incubation at 
37 oC, transformants grown on LB plate against kanamycin was randomly selected and 
those which were confirmed to bear BmHYA1 gene were subcloned into BL21 competent 
cells. The subcloning resulted in an expression of BmHYA1 fusion protein with a GST or 
His tag. The structures of the recombinant expression vectors are indicated in Fig.3.34. 
         
 
(A) 
        BamHI 
TAT CGG GGA TCC ACA TCT GCC GAC TTT AAG GTG  
 Y   R   G   S   T   S   A   D   F   K   V 
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                            XhoI 
……TGT CAA ATT GCA CCT TGA CTC GAG




CAT ATG CAT CAC CAT CAC CAT CAC ACA TCT GCC GAC 
         H   H   H   H   H   H   T   S   A   D 
 
                            XhoI 
……TGT CAA ATT GCA CCT TGA CTC GAG
…… C   Q   I   A   P  Stop 
 
Fig. 3.34. Nucleotide and amino acid sequences at the region of vector-gene fusion. The 
nucleotide and the amino acid sequences flanking the vector-BmHYA1 gene are shown. 
(A) for GST purification, with BamH I and Xho I restriction sites. (B) for His purification, 
with Nde I and Xho I restriction sites. Restriction sites are underlined. The sequence ACA 
TCT GCC was artificially coded based on Edman degradation result Threonine-Serine-
Alanine, shown in italics. Stop codon TGA is shown in bold type. 
       
        3.13.5.2 Expression of recombinant BmHYA1 
        Transformed BL21 competent cells were incubated on LB plate (with 50 µg/mL 
kanamycin) overnight at 37 oC. A single clone was incubated in 5 mL LB-kanamycin 
medium overnight at 37 oC with shaking at 220 rpm. Two milliliters out of the previous 5 
mL of the inoculated medium was added into 100 mL LB-kanamycin medium (1:50 
inoculation). The OD 600 of the medium increased to about 0.5 after 100 minutes with 
the constant shaking at 220 rpm. The expression of recombinant BmHYA1 was induced 
 116
 
Chapter 3: Results and Observations 
by the addition of IPTG. After 4 hours of IPTG addition, the medium was collected for 
protein examination. As indicated in Fig. 3.35, a protein with apparent M.W. of 65 kDa 
was purified by GST tag, which appeared to be more or less in agreement with the M.W. 
of BmHYA1 (deglycosylated) plus GST fusion protein. The recombinant GST fusion 
BmHYA1 was soluble, but no obvious activity was detected.  In contrast, His-tagged 
recombinant BmHYA1 was expressed as inclusion body. Apparent protein band at 
expected M.W. position was detected in whole cell lysates, but no corresponding band 
was found in supernatant, and nothing was purified from the supernatant (Fig.3.36 (A)). 
Hence the pellet was denatured to extract the insoluble proteins. Finally, His-tag 
BmHYA1 was purified from the pellet under denaturing condition. As expected, the M.W. 
of recombinant His tag BmHYA1 was found to be fairly close to 45 kDa. (Fig.3.36 (B)) 
 
3.14 The biological activity investigation of BmHAY1 
 
    3.14.1 Direct effect of BmHYA1 on cultured cancer cells 
    The human breast cancer cell line of MDA-MB-231 is an aggressive cancer cell line 
that supposedly contains much hyaluronan. Using bHABP (biotinylated HA-binding 
peptide) as a probe to stain the hyaluronan in the fixed cells, MDA-MB-231 showed 
abundant quantities of hyaluronan diffused all over the cells (Fig. 3.37 (A)). MDA-MB-
231 was treated with BmHYA1 for 20 hours to examine the effect of BmHYA1 on cell 
hyaluronan breakdown. The enzyme significantly removed the hyaluronan from MDA-
MB-231 cancer cells (Fig. 3.37 (B)). Quantitative analysis of DAB staining is shown in 
Fig 3.37 (C)).   
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Fig.3.35. Examination of recombinant GST fusion BmHYA1 by SDS-PAGE (12%). 
Lane1: Protein standards (same as in Fig. 3.1); lane 2: eluate collected from GST affinity 
chromatography column; lane 3: supernatant of bacterial lysate; lane 4: bacterial whole 
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Fig.3.36. Examination of recombinant His-tagged BmHYA1 by SDS-PAGE (12%). (A) 
Supernatant of bacterial lysate after centrifugation. Lane1: Protein standards (same as in 
Fig. 3.1); lane 2: blank; lanes 3~6: elution buffer from nickel column (with 10, 20, 75, 
250 mM imidazole, respectively); lane 7: bacterial supernatant after centrifuge; lane 8: 
whole cell lysate. (B) Lane1: protein standards (same as Fig. 3.1); lane 2: whole cell 
lysate; lane 3: bacterial pellet after centrifugation; lanes 4~7: elution buffer from nickel 
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    3.14.2 BmHYA1 and the expression of CD44 isoforms 
    To study the effect of environmental hyaluronidase on the expression of CD44 
isoforms, western blot was used to examine the expression change of CD44 molecules 
after the breast cancer cells were incubated with BmHYA1 for different time courses. As 
shown in Fig.3.38, the expression of CD44v6 was reduced when MDA-MB-231 cancer 
cells were treated with BmHYA1 for 48 hours while the expression change was not 
























































Fig.3.37. Immunohistochemical staining of hyaluronan on MDA-MB-231 cancer cells, 
with or without treatment with BmHYA1. The cells were incubated at 37 oC for 20 hours 
before staining with biotinylated HA-binding peptide (bHABP) overnight at 4 oC, 
followed by washing and 1 hour incubation with avidin-labeled horseradish peroxidase 
solution. (A): Cancer cells without BmHYA1 treatment (control); (B): MDA-MB-231 
cells with BmHYA1 treatment. (C): Quantitative analysis of DAB staining for the control 
(untreated) and BmHYA1-treated MDA-MB-231 cells. Cells (n = 9) were randomly 
























Fig.3.38. The effect of BmHYA1 on CD44v6 expression in MDA-MB-231 cancer cell 
line. Upper panel: A representative western blot. Lower panel: Quantitation of the 
immunospecific band for different time points, with and without treatment, respectively. 
The cells were treated with BmHYA1 for up to 48 hours. There was a significant 















Chapter 4: Discussion 
4.1 The protein content of crude scorpion venom  
        The protein content of BCV, as measured by Bio-Rad protein assay, was about 36% 
of its dry weight. This amount was comparable to 39.04% protein content found in the 
crude venom of the scorpion Heterometrus scaber (Nair and Kurup, 1975). In contrast to 
scorpion venoms, up to 90% of the dry weight of the crude venoms of snakes was found 
to be proteins (Mebs, 1969). Bieber (1979) also reported that serine and metalloproteases, 
PLA2 and LAAO of snake venoms comprised more than 90% of the dry venom weight. It 
seems therefore that the protein content of venoms varies between the snake and scorpion 
species. While the proteins constitute as a principal component in snake venoms, 
scorpion venoms, on the other hand, contain less proteins. A corresponding increase in 
non-protein components (e.g., serotonin, histamine, acetylcholine and norepinephrine) 
might therefore be present in scorpion venoms than that found in snake venoms. The 
significance of the difference in protein abundance between scorpion and snake venoms 
might be worthy of further investigation. 
 
4.2 The biological activities of BmK venom 
        BmK venom has been intensively investigated and even considered as the most 
studied scorpion venom so far (Goudet et al., 2002). However, the high M.W. proteins of 
this venom might have not yet been addressed in detail before this study. It is remarkable 
to note that quite a number of high M.W. proteins, such as serine protease, 
metalloproteinase, phospholipases and hyaluronidases, have been purified, characterized 
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and tested from the snake and bee venoms for medical significances (see reviews 
Markland, 1997; Clemetson et al., 2007; Lee et al., 2008). The high M.W. proteins from 
the scorpion venom, in spite of the attraction that its low M.W. peptides have received as 
a source of potential therapeutics, await possible exploitation for drug development. Their 
characterization should also assist in performing comparative studies between scorpion 
venoms and those from other species. Hence in screening the biological activity, 
emphasis was placed on the high M.W. components of this scorpion venom. The BCV 
was initially separated by the gel-filtration chromatography by virtue of the molecular 
size difference. The collected peaks from the gel filtration were also examined by SDS-
PAGE or MS to estimate the M.W. distribution of the components of each peak. The 
results clearly show that the high M.W. proteins are concentrated in peak 1 to peak 3, 
while peak 4 contains a mixture of high and low M.W. fractions, and the later peaks are 
comprised almost entirely of the low M.W. species. The SDS-PAGE data (Fig. 3.2) 
obtained with alternate fractions of eluate collected by first 4 peaks indicate that BCV 
contains many high M.W. proteins (with M.W.>14 kDa). Detection of such high M.W. 
proteins from the BCV has not been previously reported, and hence BCV can be 
considered as a rich source searching for new proteins with various biological activities. 
 
        LAAO activity  
        LAAO is known to have a number of biological activities including modulation of 
the platelet function, induction of apoptosis (Du and Clemetson, 2002), and antibacterial 
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as well as antiparasitic functions (Ciscotto et al., 2009). As detected during the initial 
screening procedure, BCV has been found to have only a weak activity. Although LAAO 
is commonly found in most snake venoms (Du and Clemetson, 2002), it is absent in a 
number of scorpion venoms including Buthotus judaicus, Heterometrus spinnifer, 
Parabuthus transvaalicus, Androctonus australis, \scorpio maurus palmatus, Leiurus 
quinquestriatus habraeus and Pandinus imperator (Tan and Ponnudurai, 1992). In 
contrast to those scorpion venoms with devoid LAAO activity, BCV contains a weak 
LAAO activity that is approximately 70% lower than that found in Naja kaouthia snake 
venom. Although it is weak, the biological activities mentioned above are required to be 
examined after the purification of the BmK venom LAAO to explore its potential 
applications. Further study of BmK venom LAAO may also shed light on the evolution of 
venom LAAOs via comparative studies performed with the snake venom LAAOs.  
 
        Fibrinogenolytic activity 
        The conversion from fibrinogen into fibrin plays an important role in blood 
coagulation. Fibrinogenolytic proteases may interfere in hemostasis via this conversion 
process. A number of fibrinogenolytic enzymes have been purified or detected from the 
venoms of snakes (Shimokawa and Takahashi, 1995; Paes Leme et al., 2008), centipedes 
(Malta et al., 2008), and spiders (Feitosa et al., 1998; Barbaro et al., 2005). However, no 
report has been found so far on this activity from scorpion venoms. The results confirm 
that BmK venom contains fibrinogenolytic activity, and demonstrate that BmK venom 
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fractions degrade fibrinogen Aα chain, without affecting Bβ and γ chains. Fig. 3.10 (A) 
shows that the components having the fibrinogenolytic activity are concentrated in the 
first 3 peaks, indicating the high M.W. (M.W. >14 kDa) nature of these enzymes. The 
results as shown in Fig. 3.10 (B) and (C) indicate that the fractions from # 55 to 57 
contain the components with fibrinogenolytic activity. As compared to other components, 
fractions # 55 to 57 contain a discrete molecular component with a molecular size 
between 25 and 37 kDa that is absent in other fractions (Fig. 3.2), and might probably 
account for the fibrinogenolytic activity of the BmK venom. By substrate preference, the 
fibrinogenolytic enzymes can be classified into α- or β-fibrinogenase. On the basis of the 
results obtained so far with BmK venom, it could be assumed that the fibrinogenolytic 
enzyme(s) of BmK venom belongs to α-fibrinogenase. However, further purification of 
pertinent fractions followed by time course study is needed to identify and characterize 
this particular fibrinogenase. In addition, since both serine protease and metalloproteinase 
may have fibrinogenolytic activity, using PMSF, a specific inhibitor for serine protease, 
and/or EDTA for metalloproteinase, would allow differentiation of BmK fibrinogenolytic 
enzyme, according to the specific enzyme type that it belongs to. Again, the 
fibrinogenolytic activity is rarely reported in scorpion venom, further studies are thus 
required to explore its properties and potential applications with particular relevance to 
thrombosis prevention and therapy. 
 
        Hemolytic activity 
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        One of the significant effects caused by animal venoms is hemolysis. PLA2 are 
probably responsible for hemolysis for many venoms, including snakes (Atanasov et al., 
2009; Vogel et al., 1981), honeybee (Watala and Kowalczyk, 1990) and caterpillar 
(Seibert et al., 2006). Besides PLA2, some small venom-derived peptides may also 
account for the hemolytic effect, like Melittin, a 26-amino-acid long peptide from 
honeybee venom, and some snake cardiotoxins (Fletcher et al., 1996). In this experiment, 
hemolytic activity was identified in all the 10 chromatographic peaks of BmK venom. 
The tests were conducted separately for each fraction using (1) whole blood and (2) red 
blood cells (RBCs) as substrates. 
        1) On the whole blood, both low and high amounts of BCV showed little effect on 
the blood cells, whereas all the semi-purified fractions had positive effect, manifesting 
unambiguous hemolytic activity. This implies presence of various hemolytic factors in 
BmK venom that could directly affect the blood cells like the high M.W. enzymes (i.e., 
PLA2, LAAO, etc.), or low M.W. peptides, such as pore-forming disulfide-bridge-free 
peptides (Zeng et al., 2005). On the other hand, besides “direct factors”, some other 
elements like anticomplementary factors might have effect on the hemostatic system and 
indirectly affect the blood cells. Therefore, the concrete elements present in BmK venom 
responsible for the whole blood hemolysis are still required the further evidence to 
confirm.  
        2) Purified RBCs were used instead of the whole blood to explore the hemolytic 
factor that could directly affect the RBC. BCV had apparently lower hemolytic effect 
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than that of the fractions, which might be due to the relatively lower concentration of 
active components present in it. In the high molecular weight fractions (peak 1~3) the 
hemolytic effect could be due to the enzymes such as PLA2 (Jenkins and Olds, 2004), 
which could directly damage the RBC membrane, while the effect shown by low 
molecular fractions (peak 4~10) might probably be caused by the peptides with no 
disulfide bonds, which could form pores in cell membrane with the subsequent release of 
hemoglobin (Nomura et al., 2004; Nomura et al., 2005). Further studies are needed to 
elucidate the components which are responsible for the effect.  
        A very slight hemolytic effect of the crude venom observed on the whole blood and 
RBC may be due to the presence of relatively low concentration of the effective 
components in each test sample, or there may be some non-protein protective 
components in the crude venom. The hemolytic effect of scorpion venom has been 
studied to a limited extent only. Venkaiah et al. (1983) found the indirect 'complement 
like' hemolytic effect of the scorpion Heterometrus fulvipes venom and stated that it had 
no direct hemolytic effect on RBC. Bertazzi et al. (2005) reported that Tityus serrulatus 
scorpion venom can activate complement system and indirectly cause hemolysis as well 
as the inflammatory effect. Up to now, no specific factor that is responsible for the 
particular effect has yet been identified. Based on the results obtained from this study, it 
seems possible that both direct and indirect hemolytic factors might probably be present 
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        Anti-bacterial activity 
        Using the Naja Kaouthia snake venom containing confirmed anti-bacterial activity 
(Mukherjee, 2007) as a positive control, the BmK venom was found to be devoid of such 
activity. As showed in Fig. 3.13, BCV and all the 10 fractions showed no antibacterial 
activity even when the amount of BCV was increased to 1 mg.  In contrast, Naja kaouthia 
crude venom showed strong antibacterial activity when used at only one tenth the amount 
of BCV (i.e., 100 µg). Recently, a novel class of non-disulfide-bridged peptides with 
unique antimicrobial activity has been successfully cloned from BmK venom gland (Zeng 
et al., 2005). In view of this, the presence of compounds with antibacterial activity in 
BmK venom could not be entirely ruled out. It is possible that such antimicrobial peptides 
may be present in BmK only in trace quantities which could make it impossible for 
detection because of their low abundance. On the other hand, for high M.W. proteins, 
since LAAO and PLA2 enzymes are also known to possess antibacterial activity, it could 
reasonably be assumed that such enzymatic components in BmK venom might also be 
present in low or trace amounts only or they have relatively weak antibacterial activity 
(for this particular bacterial strain DH5α). Nevertheless, other bacterial strains than DH5α 
are needed to be tested for further antibacterial study of BmK venom. 
 
        Amidolytic activity 
        Amidolytic activity is commonly found in animal venoms. For example, serine 
protease and metalloproteinase may both have amidolytic activity. Amidolytic activity 
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was detected in peak 2 of BmK fractions collected after chromatography. Venom 
amidolytic enzymes were mainly found in snake venoms (Zhu et al., 2005; Salazar et al., 
2008). In 2007, He et al. identified a serine protease gene from a sea snake venom gland, 
and the recombinant protein showed amidolytic activity. Although the enzyme with 
amidolytic activity was rarely reported for scorpion venoms, the results obtained in this 
study with BmK venom indicate that this scorpion venom also contains the enzymes with 
amidolytic activity. Hence, further study is required to characterize the protein, and to 
identify whether it is a serine protease or metalloproteinase. It would be interesting to 
compare this enzyme from BmK venom with other venom amidolytic enzymes from 
other scorpions or other venomous animals. 
 
        PLA2 activity 
        PLA2 enzymes are commonly found in most animal venoms. They are secreted from 
the venom gland hence all are secretory PLA2s. Venom PLA2s have various 
pharmacological effects including neurotoxicity (Strong et al., 1976), cardiotoxicity (Lee 
et al., 1977), myotoxicity (Ponraj and Gopalakrishnakone, 1995), anticoagulant (Verheij 
et al., 1980), antiplatelet (Huang et al., 1997) and hemolytic activity (Condrea et al., 
1981). PLA2s are mostly found in snake venoms, and are also present in the venoms of 
honeybee and lizard (Kini, 1997; Scott et al., 1990; Sosa et al., 1986). As compared to 
intracellular PLA2s, which have high M.W.s of 31~110 kDa (Mukherjee et al., 1994), the 
venom PLA2s have a relatively lower M.W. ranging from 13 to 15 kDa (Kini, 1997). 
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Despite numerous reports available on snake and bee venoms, reports on scorpion venom 
PLA2s are hardly found in the literature. Up to now, only one PLA2 (IpTxi) has been 
reported from scorpion (P.imperator) venom (Zamudio et al., 1997). IpTxi has a M.W. of 
about 15 kDa, which is within the acceptable range of M.Ws established for venom 
PLA2s. However, the PLA2 activities identified in this study were located in peak 1 
(around fraction #49) and in between peaks 2&3 (around fraction #61). According to 
M.W. estimations based on the SDS-PAGE size distribution profile, the apparent M.W.s 
of the two components were found to be more than 100 kDa and around 37 kDa, 
respectively, which are considered much higher than the commonly M.W. range of 
sPLA2s reported. On the basis of M.W, it appears likely that the enzyme(s) containing 
PLA2 activity in scorpion BmK venom might be classified as a new class of PLA2. 
Nevertheless, further purification is necessary to obtain the enzymatically active 
compound(s) from the fractions to confirm the presence of PLA2 in BmK venom.   
 
        Hyaluronidase activity 
        Hyaluronidase activity was detected in peak 2, which contained mainly the proteins 
with M.W. ranging from 19 to 60 kDa, as indicated in SDS-PAGE profile. The M.W. of 
hyaluronidase obtained from BmK venom is in agreement with those of other scorpion 
venom hyaluronidases − 47.5 kDa (Centruroides limpidus limpidus, Cevallos et al., 1992), 
51 kDa (Tityus serrulatus venom, Pessini et al., 2001), and 52 kDa (Palamneus 
gravimanus venom, Morey et al., 2006). This hyaluronidase was studied further in detail.  
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        In summary, BmK venom had been found to contain various enzymes besides the 
abundantly present peptide toxins. In an attempt to look for high M.W. proteins from 
BmK venom, proteins with various biological activities having M.W.s of over 14 kDa 
were discovered. BmK venom contains hyaluronidase and LAAO enzymes, and most 
probably contains serine protease, metalloproteinase and/or PLA2s, but their presence in 
the venom could not be confirmed at present.   
 
4.3 Purification and characterization of BmHYA1 
        BmHYA1 was purified from BCV by 3 stages of chromatography involving gel-
filtration, ion-exchange and RP-HPLC. The fact that BmHYA1 was eluted at 
approximately 70% gradient level of solution B (1 M NaCl and 0.05 M sodium acetate) 
of cation exchange chromatography indicates that it is a very basic protein like most other 
venom hyaluronidases. As expected, the theoretical pI value of BmHYA1 is later 
calculated to be 8.65 (see table 1.1). Its M.W, as measured by SDS-PAGE and MALDI-
TOF, was found to be 48 kDa and 48,696 Da, respectively. The M.W. estimated from 
SDS-PAGE is in agreement with that of MALDI-TOF result. Comparison of the M.W.s 
of BmHYA1 and other scorpion venom hyaluronidases: 47.5 kDa from Centruroides 
limpidus limpidus venom (Cevallos et al., 1992), 51 kDa from Tityus serrulatus venom 
(Pessini et al., 2001), and 52 kDa from Palamneus gravimanus venom (Morey et al., 
2006) − indicates that BmHYA1 is generally similar in M.W. to other scorpion venom 
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hyaluronidases. The only exception is the M.W. (82 kDa) of Heterometrus fulvipus 
venom hyaluronidase (Ramanaiah et al., 1990), which is much higher than those of all the 
other known scorpion venom hyaluronidases, including BmHYA1. 
 
        The optimal activity of BmHYA1 (pH 4.5) is similar to that determined for the 
Indian scorpion (P. gravimanus) venom hyaluronidase (Morey et al., 2006), but different 
from the optimal pH reported for hylauronidases (6.0 and 4.0) from the venoms of T. 
serrulatus (Pessini et al., 2001) and Heterometrus fulvipus (Ramanaiah et al.,1990), 
respectively. It is noteworthy that the optimal pH of all scorpion venom hyaluronidases 
are all well below 7, and none of such enzymes discovered so far from all animal venoms 
appear to display the optimal activity at a basic pH (Kemparaju and Girish, 2006; Girish 
et al., 2002). This indicates that scorpion venom hyaluronidases do not show any 
apparent activities at pH higher than 7.0.  
 
        Interestingly, the optimal temperature (50 oC) of the scorpion venom BmHYA1 turns 
out to be more similar to that of the bovine testicular hyaluronidase (Meyer et al., 1960) 
than to the optimal temperatures of other venom hyaluronidases, including those from 
scorpion venoms T. serrulatus and P. gravimanus. The optimal temperatures of those 
venoms are usually found to be in the relatively lower range of 37~40 oC (Kemparaju and 
Girish, 2006; Pessini et al., 2001; Girish et al., 2002; Morey et al., 2006). Surprisingly, it 
was found that BmHYA1 exerted escalating activity with the rising temperature up to 50 
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oC. A comparison was made with Naja kaouthia venom hyaluronidase and bovine 
testicular hyaluronidase to confirm this phenomenon. The results showed that the optimal 
temperature of Naja kaouthia venom hyaluronidase was 37 oC, whereas the bovine 
testicular hyaluronidase showed the maximal activity at 50 oC, which was consistent with 
the report by Meyer et al. (1960). These findings may suggest that BmHYA1 shares some 
common physicochemical characteristics with mammalian hyaluronidases but differs 
from those of other venom hyaluronidases. For the effect of temperature on the enzyme, 
the activity of the enzyme decreased slightly with the gradual increase in temperature 
from 4~24 oC, but lost its activity rapidly from 24 °C onwards, indicating it is sensitive to 
temperature changing at relatively high temperature. 
  
        BmHYA1 has the Km of 95.3 µg/mL, which is not much distinct from the Km values 
of the enzymes from P. gravimanus (47.61 µg/mL) (Morey et al., 2006) and T. serrulatus 
(69.7 µg/mL) (Pessini et al., 2001). Its catalytic efficiency is much higher than that of 
stonefish venom hyaluronidase, which has a Km of 709 µg/mL (Poh et al., 1992), but is 
much lower than that of Potamotrygon motoro fish venom hyaluronidase, whose Km is 
4.91 µg/mL.  
 
        BmHYA1 can be inhibited by heparin, Fe3+ or Cu2+, but is unaffected by Mg2+, Ca2+ 
or EDTA. Heparin, a non-specific inhibitor to hyaluronidase (Mio and Stern, 2002), is 
able to inhibit hyaluronidases from the venoms of the snake Agkistrodon acutus (Xu et al., 
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1982), scorpions Heterometrus fulvipus and Palamneus gravimanus (Ramanaiah et al., 
1990; Morey et al., 2006) and stonefish Synanceja horrida (Poh et al., 1992), indicating 
that heparin has a wide inhibitory spectrum to venom hyaluronidases. The inhibition of 
heparin to hyaluronidase is non-competitive through formation of a local enzyme 
complex. As deduced by a Lineweaver-Burke plot, heparin does not bind to the catalytic 
site of hyaluronidases (Mio and Stern, 2002). 
 
        In deglycosylation assay, the shift was observed only with PNGase F treated 
BmHYA1 (between lane 2 and any lane of 3, 4, or 5 in Fig. 3.27), but not by that treated 
with either α-2(3,6,8,9)-Neuraminidase or O-Glycosidase (among lanes 3, 4, and 5). 
According to the product manual, the ability to detect obvious mobility shifts is based on 
the size of the protein and the relative mass contribution of the sugars removed. If a large 
protein with a small amount of O-linked sugars is treated with O-Glycosidase, it may be 
difficult to set up the relationship between the presence of O-linked sugars and the 
mobility shifts of the proteins. From Fig. 3.27, the marked shift between lanes 2 and 3 
was the result of the removal of N-linked sugars by PNGase F, thus indicating the 
presence of N-linked sugars. No obvious shift was detected among lanes 3, 4 and 5, 
which may suggest that little or no O-linked sugar is present in the protein. The overall 
result indicates that BmHYA1 is a glycoprotein consisting of mainly, if not all, N-linked 
sugars. As one of the most important post-translational modification, glycosylation is 
commonly found in animal venom proteins. It plays a crucial role in various biological 
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processes including protein folding, activity exertion and pharmacokinetic stability 
(Soares and Oliveira, 2009). All the venom hyaluronidases that have been examined so 
far turn out to be glycoproteins, with the only exception being the hyaluronidase (two 
isoforms) from the N. naja snake venom. Negative result was obtained for N.naja venom 
hyaluronidase with PAS staining test (Girish et al., 2004; Girish and Kemparaju, 2005). 
The venom hyaluronidases which have not been conducted for glycosylation test may 
also show the potential N-glycosylation sites when their full sequences were deduced and 
analyzed (Gmachl and Kreil, 1993; Ng et al., 2005; Harrison et al., 2007). The findings of 
potential N-glycosylation sites on their molecules strongly suggest that they would be 
also glycoproteins, and it might be therefore assumed that most of the venom 
hyaluronidases are glycoproteins.  
 
4.4 The N-terminal amino acids sequence of BmHYA1  
        Up to date, amino acid sequences of a number of hyaluronidases from different 
sources have been identified with sequence homologies noted among them (Kemparaju 
and Girish, 2006; Stern and Jedrzejas, 2006). The amino acid sequence of the yellow 
jacket wasp venom hyaluronidase shows 92% and 53% identities respectively, with the 
hylauronidase sequences of the white faced hornet and honeybee venoms (King et al., 
1996). The honeybee venom hyaluronidase exhibits some sequence identity with PH-20, 
the sperm surface hyaluronidases involved in sperm-egg adhesion, while a number of this 
PH-20 mammalian sperm protein family members have about 45% sequence identity 
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with the stonefish venom hyaluronidase SFHYA1 (Gmachl and Kreil, 1993; Ng et al., 
2005). For the scorpion venom hyaluronidases, though a few enzymes have been isolated 
and characterized, the sequence information is rather limited. Before this N-terminal 
amino acid sequence from the present work, the only partial sequence information (24 N-
terminal amino acids) was from the scorpion T. stigmurus venom (Batista et al., 2007). 
Comparison of the N-terminal sequences between BmHYA1 and the hyaluronidase from 
the venom of scorpion T. stigmurus indicates that the two cysteines as well as a lysine are 
located at the same positions, but no other identical residue is found in the remaining 
region (Fig. 3.22 (B)). Cysteines in peptides cross link with each other to form disulfide 
bridge(s), which provide the backbone for peptide folding. The identical cysteine 
positions of the two scorpion hyaluronidases noted in the present study may suggest the 
possibility of having a similar backbone to a certain degree in some scorpion venom 
hyaluronidases. In contrast, some sequence similarity is noted among BmHYA1 and other 
N-terminal sequences of honeybee and stonefish venom hyaluronidases (Fig. 3.22 (A)). 
The comparison of thirty N-terminal amino acids of these three venom hyaluronidases 
indicates that they share identities to a certain degree. BmHYA1 shares approximately 
30% of identity to honeybee venom hyaluronidases and 17% of identity to SFHYA1, 
respectively. The position of first cysteine of BmHAY1 is exactly the same as that found 
in both of these two proteins. Ng et al. (2005) stated that to get full cDNA sequence of 
SFHYA1, initial experiment which was based on the previously reported first 20 N-
terminal amino acid residues of SFHYA1 (Poh et al., 1992), was unsuccessful and this N-
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terminal sequence was later considered to be incorrect. The fact that BmHAY1 has a 
common feature in N-terminal sequence with other family members suggests the result 
obtained with Edman degradation is reliable. Further studies are required to solve the 
complete structure of scorpion venom hyaluronidase in order to understand the function 
of this enzyme and to elucidate the structure-function relationship.  
 
4.5 The cloning and expression of BmHYA1 
        The first step of this work was to construct the cDNA library of venom gland. The 
quality of the library is the cornerstone of the whole following work. In 2001, Zeng et al. 
reported that for the construction of a BmK venom cDNA library, 60 scorpions had to be 
sacrificed. Five micrograms of mRNAs obtained from the venom glands of these 60 
scorpions were then used for converting to cDNAs, and the ligated cDNAs were finally 
introduced into E.coli cells to complete the construction of cDNA library. In contrast, 
Schwartz et al. (2007) recently analyzed the transcriptome of the venom gland of a 
Mexican scorpion Hadrurus gertschi using only a single pair of glands. Likewise, only 
one pair of glands was used for the molecular level study of BmK venom hyaluronidase, 
suggesting that a pair of venom glands from a single scorpion is enough for the RACE 
PCR cloning of not-so-rare molecular copies. On the other hand, according to the report 
by De Lucca et al., (1974), secretion of the secretory epithelium of a snake venom gland 
was most active after 4 days of milking. As a rule, the RNA extraction from the venom 
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glands are done following 1~4 days of milking thus allowing the gland epithelium cells to 
grow to secretory phase for maximal output of the RNA (e.g., Zeng et al., 2001; Schwartz 
et al., 2007). The present work was accomplished without such pre-treatment applied on 
the animal. The animal was normally reared and had not been milked before the sacrifice. 
It indicates that the stimulus of gland epithelium before RNA extraction may not be 
necessary for a common cloning work.  
 
        The present work provides the full-length deduced amino acid sequence of 
BmHYA1, the hyaluronidase from the venom of BmK. This work presents the first 
successful molecular characterization of the hyaluronidase from the scorpion venom. The 
5’ degenerate primer was designed based on the N-terminal sequence. As mentioned 
before, the lyophilized venom are collected and mixed from a significant number of 
scorpions (1 gram from 3000 scorpions). Hence the N-terminal sequence information of 
the protein from the lyophilized venom can be thought of as the representative for this 
species. Considering that the deduced sequence shares almost the exact N-terminal 
sequence with the experimental Edman degradation result, it should be also the 
representative sequence for this particular species. The deduced amino acid sequence 
together with the N-terminal sequence obtained with the Edman degradation designate 
the completely mature BmHYA1 protein sequence. The N-terminal sequence of mature 
BmHYA1 as deduced from the sequence of the cloned cDNA is in agreement with the 
sequence information obtained by Edman degradation, except for the 23rd position. The 
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deduced amino acid at 23rd position is an asparagine whereas by Edman degradation there 
is a cysteine. Since cysteine does not show the signal in Edman degradation 
chromatogram, it seems possible that some small peaks may be overlooked and hence 
misinterpreted as cysteine. The deduced result is assumed to be more reliable under the 
present circumstances.  
 
        The mature BmHYA1 comprises 385 amino acid residues. As for the mature protein, 
the number of amino acid residues of BmHYA1 is comparable to those encoded by some 
known hyaluronidase cDNAs from other species like human HYAL-1 (384 aa, 
CAG46731.1), but less than many of other known hyaluronidase enzymes, e.g., C. 
elegans hyaluronidase (436 aa, CAA88874.1) and Guinea pig PH-20 (494 aa, 
CAA39768.1). BmHYA1 has a theoretical M.W. of 44,549 Da. The difference observed 
between the theoretical and the experimental (48,696 Da) M.W.s is attributable to the 
post-translational modification of BmHAY1. Presumably it would be N-glycosylations 
since five potential N-glycosylation sites (N-X-S/T) are found in the deduced sequence.  
These five sites are: N23-V-T, N86-I-S, N231-T-S, N360-P-T, N367-I-S, respectively (see Fig. 
3.31). It is notable that the number of potential N-glycosylation sites of BmHYA1 is more 
than the hyaluronidases of honeybee (Gmachl and Kreil, 1993) and SFHYA1 (Ng et al., 
2005), both of which contain only 3 sites. The hyaluronidase Eo Hy-1 from snake Echis 
ocellatus venom has also 5 potential N-glycosylation sites (Harrison et al., 2007).  Their 
contribution to the M.W. of the native enzymes needs to be determined. It is also notable 
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that none of the five potential N-glycosylation sites in BmHYA1 sequence represents in 
other hyaluronidase sequences. Meanwhile, BmHYA1 also lacks of the highly conserved 
potential N-glycosylation site of hyaluronidases (positions 323-325 of BmHYA1 
sequence, see Fig. 3.32). It may suggest that BmHYA1 possess certain special structure, 
compared with other hyaluronidases.  
 
        BmHYA1 has 12 cysteines and these cysteines might have different suggestions (Fig. 
3.32). It has been elucidated that the two disulfide bonds of honeybee venom 
hyaluronidase are formed by Cys22-Cys313 and Cys189-Cys201 (Marković-Housley et al., 
2000). In BmHYA1 sequence, it could be seen that the conservation of cysteine residues 
at Cys16 and Cys306 as well as Cys181 and Cys195 indicates this scorpion venom 
hyaluronidase has probably the same partial structural feature as honeybee venom 
hyaluronidase. Similarly, the conservation of Cys331, Cys336, Cys342, Cys370, Cys372 and 
Cys381 between BmHYA1 and hyaluronidases other than honeybee venom hyaluronidase, 
may also suggest the structural significance of BmHYA1, though it remains as a 
conjecture since no experimental evidence is available at this point so far. Still, we notice 
that Cys174 and Cys217 are not consensus at all with any other hyaluronidases. It might be 
assumed that these two cysteines form special disulfide bond of BmHYA1 and hence 
likely lead to its special structural property.  
 
        In 2007, Batista et al. reported the first partial amino acid sequence of the scorpion (T. 
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stigmurus) venom hyaluronidase. BmHYA1 was initially found to have two cysteine 
residues in N-terminal sequence identical to those of this T.stigmurus scorpion venom 
hyaluronidase, hence it was assumed that these cysteines may form special structure for 
scorpion venom hyaluronidases (Feng et al., 2008). Further investigation revealed that the 
sequence of this T. stigmurus scorpion venom ‘hyaluronidase’ may not belong to 
hyaluronidase family. It is almost identical to the N-terminal amino acid sequence of an 
allergic protein from Brazilian yellow scorpion (Tityus serrulatus) venom (Swiss-Prot 
accession no. P85840.1), and also has higher similarity to N-terminal sequences of other 
allergic proteins (e.g., Swiss-Prot accession no. P85860.1, GenBank accession no. 
ABX75373.1, both from spider venoms) than those of hyaluronidases. Hence it is highly 
unlikely that the protein could be hyaluronidase. On the other hand, as mentioned above, 
from the deduced BmHYA1 sequence, it was found that the 23rd position of BmHYA1 is 
not a cysteine, but an asparagine. The former was experimentally obtained by Edman 
degradation. This discrepancy may be due to the misreading of Edman degradation 
chromatogram. Since cysteine showed no signal in the graph, it seemed likely that some 
weak peak may escape detection and hence recognized as cysteine by mistake. If it is true, 
the total number of cysteines is 12, which is in agreement with the usual status of even 
number of cysteines, to form the disulfide bonds. Therefore it is assumed that the second 
cysteine, which is located at the 7th position downstream to the first cysteine in BmHYA1 
N-terminal sequence, may not exist. However, a new hyaluronidase N-terminal sequence 
(34 amino acids, Swiss-Prot accession no. P85841.1) from the venom of Brazilian yellow 
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scorpion (Tityus serrulatus) demonstrates that the second cysteine appears at the 7th 
position downstream to the first cysteine and also has high identity with the N-terminal 
sequence of BmHYA1 (Fig. 4. 1). If it is the case that the 23rd residue in BmHYA1 
protein sequence is really a cysteine, but not an asparagine, it may strongly suggest that 
there should be still a special structure in scorpion venom hyaluronidases. Nevertheless, 




                                    
            10         20         30           Source 
   TSADFKVVWE VPSIMCSKKF KICVTDLLTS HKILVNQ    (A) 
      KFKVYWE VPSFLCSKRF KICVTEVLTS HEILVNQ    (B) 
 
                                    
 
Fig .4.1. The comparison of N-terminal sequences of (A) BmHYA1 (Feng et al., 2008; 
present work) and (B) Brazilian yellow scorpion (Tityus serrulatus) venom hyaluronidase 
(Swiss-Prot accession no. P85841.1). The two sequences are highly identical and both 
have the 6-amino-acid-residue interval between the two cysteines. The identical residues 
are shaded and the cysteines are highlighted in white color. The 23rd amino acid residue 
(the second cysteine position, underlined) in BmHYA1 sequence is asparagine as deduced 
by nucleotide sequence. 
 
        The other structural characteristic of interest of BmHYA1 is the determinants for its 
catalytic action. Based on the three-dimensional structure analysis of honeybee venom 
and bovine PH-20 hyaluronidases, a cleft in both proteins is a potential catalytic site, 
which contains a catalytic Glu and a number of positioning residues. The mutation of 
involved residues may lead to the alteration of enzymatic behaviors (Stern and Jedrzejas, 
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2005). In the deduced BmHYA1 protein sequence, the corresponding elements are also 
identified. The catalytic Glu is located at the 105th position of BmHYA1, and the 
surrounding positioning residues are supposed to be Asp103, Tyr176, Tyr221 and Trp294, 
which are exactly the residues located at the equivalent positions of the tertiary structures 
of honeybee venom and bovine PH-20 hyaluronidases (Fig. 3.22). It has been suggested 
that the substrate specificity difference of Human HYL-4 is attributable to mutation in the 
positioning residues of Tyr to Cys (263rd position) in Human HYL-4 (Stern and Jedrzejas, 
2005. Note: Cys263 has been updated to be Gly263 in sequence version 2). Hence it seems 
likely that BmHYA1 might have the same substrate specificity as that of honeybee venom 
hyaluronidase and bovine PH-20. 
        The expression of BmHYA1 was carried out in E.coli expression system, which is 
the method of choice for heterologous expression of recombinant proteins due to its 
capacity to produce abundant recombinant proteins and easy manipulation. Enzymatically 
active recombinant venom hyaluronidase has been successfully expressed in E.coli 
system (Gmachl and Kreil, 1993). In that work, the recombinant bee venom 
hyaluronidase was purified from the inclusion bodies. After reduction and refolding, the 
recombinant protein demonstrated about 80% of the native hyaluronidase activity. 
However, several failed trials had also been reported in heterologous expression of 
hyaluronidase in E.coli system. Gmachl et al., (1993) reported that recombinant human 
PH-20 hyaluronidase expressed from E.coli failed to show any detectable activity. Ng. et 
al. (2005) successfully cloned stonefish hyaluronidase SFHYA1 cDNA and expressed it 
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in insect cells in its active form, but not in E.coli. In a more detailed expression study, 
Soldatova et al. (1998) compared the bee venom hyaluronidase expression in prokaryotic 
and eukaryotic systems, and revealed that the protein expressed in insect system had the 
activity comparable to the native protein, while the protein expressed in E.coli formed 
inclusion body with the reconstituted protein showing only 20~30% of the activity of the 
native bee venom hyaluronidase. This indicates that the post-translational modifications, 
such as glycosylation, may play a key role for correct conformation of the hyaluronidases. 
In the present work, E.coli expression system was employed, along with the two 
purification tags, i.e., GST and His. GST improves the solubility of the recombinant 
protein and at the same time providing a tag for protein purification, hence it is 
commonly used as an expression tag in recombinant protein production. The result 
obtained from the GST tag expression and purification showed that the expression level 
was not satisfactory, and the protein turned out to have no enzymatic activity. Since the 
E.coli system is not efficient enough to provide appropriate post-translational 
modification, it is likely that the protein may fail to fold properly. Another possibility is 
that the size of BmHYA1 is not much bigger than that of GST, and this may influence the 
biological activity of recombinant BmHYA1. To counteract this effect, His tag was 
employed as an alternative purification strategy. Although His tag is relatively smaller in 
size containing only 6 Histidine residues, it may cause aggregation of the heterologous 
protein in the host cells, and that was what happened in the present work. The protein was 
insoluble and additional reducing and refolding process should be taken to reconstitute 
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the protein for further study. Otherwise the eukaryotic expression system, such as insect 
cells, may be introduced.  
 
4.6 Biological activities of BmHYA1 
        Hyaluronidase can degrade hyaluronan to a wide range of fragments in different 
sizes. Human HYAL-2 degrades hyaluronan to 20 kDa products (Lepperdinger et al., 
2001) while Human HYAL-1 hydrolyzes the substrate into tetrasaccharides (Csoka et al., 
2001). Among the five hyaluronidases of human origin, only these two are well 
characterized. Further related studies have been done for the hyaluronidases from venoms. 
Sugahara et al. (1992) studied the reaction product of the stonefish venom hyaluronidase 
and found the products to be mainly tetra-, hexa-, octa- and deca-saccharides, while no 
disaccharides were found. The hyaluronidase from Agkistrodon contortrix contortrix 
(snake) venom hydrolyzed the substrate into hexa- and tetrasaccharides (Kudo and Tu, 
2001), while the final products were tetrasaccharides for Naja naja (snake) venom 
hyaluronidase (Girish et al., 2004). BmHYA1 was supposed to be the first scorpion 
venom hyaluronidase whose final degradation production was analyzed. It was found to 
hydrolyze the hyaluronan into relatively small size oligosaccharides of tetrasaccharides 
(the degradation products of hyaluronan by venom hyaluronidases were summarized in 
table 4.1). Since low M.W. hyaluronan fragments are known to play a role in 
inflammation, immunostimulation and angiogenesis (Stern, 2005), it is possible that the 
venom hyaluronidases, besides acting as the spreading factor, may also contribute to local 
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tissue damage and inflammation through the action of hyaluronan fragments on 
connective tissue, collagen and blood vessels. 
 
Table 4.1. Comparison of the degradation products by different hyaluronidases 
Source Products Reference 
BmK, Scorpion tetrasaccharides Present work 
S. horrida, Stonefish tetra-, hexa-, octa- and 
deca-saccharides 
Sugahara et al.,1992 
A. contortrix contortrix,    
                            Snake 
hexa- and tetrasaccharides  Kudo and Tu, 2001 
N. naja, Snake tetrasaccharides Girish et al., 2004 
 
      Hyaluronan has important physiological as well as pathological functions. It is up-
regulated in breast cancer, with abundant levels of hyaluronan often found to be 
correlated with tumor aggressiveness (Götte and Yip, 2006; Anttila et al., 2000). 
Hyaluronan also plays a special role in cancer cell invasion and metastasis by interacting 
with CD44, a member of a big family of cell transmembrane glycoproteins involved in 
cell-cell and cell-matrix connections (Delpech et al., 1997). Cancer cells express high 
levels of CD44. Variants of CD44 (CD44v) are generated by alternative splicing of a 
single gene (Naor et al., 1997). Being the primary receptors of hyaluronan, they are able 
to respond to environmental hyaluronidase signals. Following 20 hours incubation of 
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cancer cell line MDA-MB-231 with bovine testicular hyaluronidase, CD44v6 mRNA was 
almost eliminated, with CD44v6 protein no longer detectable by immunohistochemical 
staining. This effect has been suggested to occur as an indirect way of eliminating the 
network-like presence of hyaluronan on the cell membrane (Stern et al., 2001). Treatment 
with bacterial hyaluronidase also resulted in the suppression of CD44 expression at tissue 
level (Laugier et al., 2000). Contrary to these findings, CD44 and CD44v mRNAs were 
reported to be up-regulated after 12-hour treatment with bovine testicular hyaluronidase 
in rabbit articular chondrocytes (Ohno-Nakahara et al., 2004), suggesting that the 
mechanisms for the CD44 modulation between human breast cancer cell and rabbit 
articular chondrocytes may be different. Our findings showed that for breast cancer cell 
line MDA-MB-231, hyaluronan was considerably removed from the cells after 
incubation with the hyaluronidase BmHYA1 for 20 hours. Based on the protein levels, it 
is suggested that the CD44v6 is down-regulated after treatment of the human breast 
cancer cell line MDA-MB-231 with BmHYA1 for 48 hours. This confirms that the CD44 
variant of cancer cells can be modulated by external signaling by way of external 
hyaluronidase treatment. The mechanism for such signaling events will be further 
investigated in relation to treating resistant cancers, which may also lead to identifying 
novel pathways for the regulation of CD44 and its variants. 
 
4.7 Future directions 
1) To continue to examine some other candidate proteins in BmK venom which were not 
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involved in the present screening, such as nerve growth factor and C-type lectin-like 
protein, and study further the identified enzymes/activities, such as LAAO, amidolysis 
and fibrinogenolysis. 
 
2) To conduct further characterization study on substrate specificity. By combining the 
information obtained from sequence alignment and phylogenetic tree of hyaluronidases, 
the evolutionary process of hyaluronidase enzyme could be well assumed.  
 
3) To obtain the full-length BmHYA1 cDNA by exploring further its 5’ end nucleotide 
sequence using RACE technique. 
 
4) To produce active recombinant BmHYA1 protein. The protein expressed by His 
purification tag can be refolded in order to get the activity recovered. Alternatively, the 
protein can be expressed by eukaryotic expression system, like insect cells Sf9. 
Furthermore, the mutagenesis studies can be carried out to investigate the structure-
function relationship.  
 
5) To study BmHYA1’s crystal structure. With abundant recombinant active BmHYA1, it 
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6) To study BmHYA1’s medical application. RNA level, tissue level and animal level 
experiments may be applied to further study the effect of hyaluronidase on CD44 
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